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Abstract 
 
NGFI-B (nerve growth factor-inducible clone B) is a nuclear receptor that has been implicated in 
both cell survival and cell death. In the nucleus, NGFI-B exerts its functions as a transcription 
factor that promotes survival and proliferation, while translocation of NGFI-B to the 
mitochondria promotes apoptosis. This unique property of NGFI-B makes it a possible 
therapeutic target. Many questions concerning the translocation of NGFI-B remain to be solved.  
 
This thesis will investigate several issues regarding the regulation of NGFI-B migration. Nuclear 
fluorescence recovery after photobleaching (FRAP)-studies in CV-1 cells suggested that the 
nuclear import of GFP-tagged NGFI-B was energy dependent, and therefore could be regulated 
by nuclear import mechanisms.  
 
The threonine 142 residue of NGFI-B was previously demonstrated to be phosphorylated by the 
MAP kinase ERK2, which is activated by growth factor EGF. Whether the nuclear import of 
NGFI-B was regulated by phosphorylation of threonine 142 of NGFI-B was investigated by 
FRAP studies of two NGFI-B mutants. A 142 threonine to alanine mutation in NGFI-B that 
blocked phosphorylation of this residue did not affect the nuclear import of NGFI-B, while a 
threonine to glutamate mutation that mimicked constitutive phosphorylation possibly decreased 
the nuclear import of NGFI-B. Additional FRAP studies showed that EGF and ERK2 reduced the 
nuclear import of NGFI-B.  
 
Cultured cerebellar granule neurons (CGN) which are extensively used in studies of glutamate-
induced toxicity, important in stroke and neurodegenerative diseases, were used as an in vitro 
model for studies of neuronal apoptosis. Cell death of CGN induced by glutamate appeared to be 
slightly reduced by inhibition of the MEK/ERK pathway, contrarily to EGF-induced ERK 
activation which is reported to be involved in neuronal survival. The translocation of NGFI-B out 
of the nucleus demonstrated by immunostaining after glutamate exposure suggests that CGN may 
be used as a model for determination of neuronal NGFI-B traffic.  
 
In conclusion, the subcellular localization of apoptosis initiator NGFI-B is regulated by MAP 
kinase ERK and apoptosis signals. 
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1  Introduction 
1.1 Nerve Growth Factor-Inducible Clone B 
Nerve growth factor-inducible clone B (NGFI-B) was originally identified in rat as a transcription 
factor that was rapidly induced by nerve growth factor (NGF) (Milbrandt, 1988). The equivalent 
protein in mouse is called Nur77 (Hazel et al., 1988), and the human homologue is termed TR3 
(Chang et al., 1989). NGFI-B, and the closely related proteins RNR-1 (also known as Nurr 1, 
TINUR and HZF-3) and Nor-1 (MINOR, CHN and TEC), form a distinct subfamily (NR4A1-3) 
within the nuclear receptor superfamily as immediate–early genes induced by multiple signal 
transduction pathways (Clark et al., 1996; de Ortiz et al., 1994; Hedvat and Irving, 1995; Labelle 
et al., 1995; Law et al., 1992; Martinez-Gonzalez and Badimon, 2005; Ohkura et al., 1994; 
Okabe et al., 1995; Scearce et al., 1993). This subgroup is classified as orphan receptors since a  
physiological ligand for the receptors has not yet been identified (Wang et al., 2003). 
 
The nuclear receptor NGFI-B has an estimated molecular mass of approximately 61 kDa (Fahrner 
et al., 1990), and is composed of four distinct structural domains. The amino-terminal A/B region 
contains the activation function 1 (AF-1) domain, which is required for the recruitment of 
transcriptional co-activators (Figure 1.1). The C region consists of a DNA-binding domain 
(DBD) with two cysteine rich zinc-finger motifs and a downstream A-box. This A box is 
essential for high affinity binding of NGFI-B to the NGFI-B response element (NBRE), which is 
within the 5'-region of target genes (Wilson et al., 1992). Monomeric NGFI-B binds to the two 5’ 
adenosine nucleotides in the NBRE consensus sequence 5’AAAGGTCA3’ (Wilson et al., 1991). 
Homodimers bind to an inverted repeat of a NBRE-related octanucleotide, the Nur-responsive 
element (NurRE) (Philips et al., 1997). The D domain includes a hinge region which participates 
in the formation of dimers. The E/F region is located to the carboxyl-terminal of the NGFI-B 
protein, and contains a dispensable transcriptional activation domain, activation function 2 (AF-
2), and also an atypical C-terminal ligand binding domain (LBD) without the classical 
hydrophobic cleft for ligand binding (Mangelsdorf and Evans, 1995; Wansa et al., 2003).  
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Figure 1.1: Schematic illustration of NGFI-B with regions A through E. 
The top panel shows the domain structure of NGFI-B, AF-1, DBD, LBD, and AF-2 (see main text for abbreviations). 
The second panel illustrates the amino acid sequence of the DBD with two C4 zinc-fingers and the D domain with 
the hinge region. The numbering is according to the full length receptor. Residues in red, pink, blue, and green 
indicate the P-box, D-box, T-box, and A-box, respectively. Solid lined boxes indicate α-helical segments, dashed 
lines indicate disordered regions. The figure is modified from Moll et al. (2006) and Meinke and Siegler (1999) . 
 
The nuclear receptor NGFI-B is constitutively expressed in most tissues (Watson and Milbrandt, 
1990), and is induced by multiple cell stimuli, including growth factors such as epidermal growth 
factor (EGF) (Moll et al., 2006). NGFI-B is frequently over-expressed in cancer cells, which 
have an unrestricted expression of growth factors. This over-expression might confer a 
proliferative advantage for tumor cells, as NGFI-B is able to promote cell growth. Ectopic 
expression of NGFI-B in lung cancer cells mediates its growth-promoting activities through 
transcriptional regulation of genes (Kolluri et al., 2003). A survival function of NGFI-B has also 
been demonstrated in vivo in the central nervous system (Zetterstroum et al., 1997). However, in 
response to apoptotic stimuli, NGFI-B is known to have an apoptotic effect in a number of cell 
types, including cancer cells and neurons (Jacobs et al., 2004; Li et al., 1998). NGFI-B induces 
apoptosis (section 1.4.3) in a transcription-independent manner by  translocating from the nucleus 
to mitochondria (Li et al., 2000). NGFI-B has no mitochondrial-targeting sequences, but binds 
via the LBD to the amino-terminal loop region of B-cell lymphoma protein 2 (Bcl-2) in the outer 
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mitochondrial membrane. The resulting conformational change of Bcl-2 converts it from a 
protector to a killer (Figure 1.2), triggering cytochrome c and apoptosis-inducing factor (AIF) 
release, and thereby apoptosis  (Lin et al., 2004). 
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Figure 1.2: Bcl-2 conversion by NGFI-B.  
The conformation of anti-apoptotic Bcl-2 is preserved by the Bcl-2 homology (BH) 3 domain-binding hydrophobic 
pocket involving the carboxyl-terminal region of Bcl-2. Binding of NGFI-B to the Bcl-2 loop interrupts the 
hydrophobic pocket, and the BH3 domain is exposed. The latter Bcl-2 conformation is pro-apoptotic. The figure is 
modified from Zhang et al. (2007). 
 
X-ray crystallography studies of the putative ligand binding site of NGFI-B revealed a closed 
conformation that would be inaccessible to ligands (Flaig et al., 2005). This suggests that the in 
vivo activity of NGFI-B is not ligand regulated. However, conclusion should not be drawn based 
solely on these findings, as the transactivation of closely related Nor-1 was found to be regulated 
by the direct binding of prostaglandin A2 to the LBD (Kagaya et al., 2005). Two possible 
mechanisms for ligand independent regulation of NGFI-B is transcriptional activation by a 
variety of signals, including mitogens, and post-translational modifications, such as 
phosphorylations (Wingate and Arthur, 2006). NGFI-B is heavily phosphorylated in a various of 
cell types in response to a number of stimuli (Davis et al., 1993; Fahrner et al., 1990; Han et al., 
2006; Hazel et al., 1991; Wingate et al., 2006; Woronicz et al., 1995). The phosphorylations are 
mainly localized in the A/B region, where 30 % of the amino acids are potential phosphorylation 
sites (Moll et al., 2006). Deletion of 152 amino acids from the N-terminal completely abolished 
mitochondrial association of NGFI-B in response to apoptotic stimuli (Li et al., 2000). The 
phosphorylation of serine 139 (105 in the mouse homologue Nur77), in the AF-1 domain has 
been implicated in a growth factor dependent nucleocytoplasmic shuttling of NGFI-B (Kang et 
al., 2000). Jun N-terminal kinase (JNK) phosphorylates an unknown residue in the A/B domain 
of NGFI-B and increase nuclear export and promote apoptosis (Han et al., 2006; Kolluri et al., 
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2003). Another phosphorylation site in the amino terminus is threonine 142, which is 
phosphorylated by extracellular signal-regulated kinase 2 (ERK2) (Slagsvold et al., 2002) 
(section 1.3). The activity of the mitogen-activated protein (MAP) kinase (MAPK) ERK2 is 
important in determining whether a cell survives or undergoes apoptosis (Chang et al., 2003). 
Phosphorylation of NGFI-B by the serine/threonine protein kinase Akt at serine 350, a site within 
the A box, inhibits DNA binding and transactivation (Hirata et al., 1993; Masuyama et al., 2001; 
Pekarsky et al., 2001).  
 
NGFI-B has three functional nuclear export signals (NES) in the ligand-binding domain (residues 
408-417, 467-476, and 520-530), and two functional nuclear localization signals (NLS) within 
the DNA binding domain. NLS1 is located within the second zinc finger domain (residues 278-
283), while NLS2 is found within the A box (residues 308-313)  (Hsu et al., 2004). The presence 
of the NESs and NLSs suggests that NGFI-B could be transported through nuclear pore 
complexes (NPCs) via the classical transport pathway (section 1.2). 
 
In summary, the nuclear receptor NGFI-B is capable of promoting both cell death and survival 
depending on the stimuli. The subcellular localization of NGFI-B is essential for its biological 
effects, since it functions in the nucleus to induce gene regulation and proliferation, and on the 
mitochondria to induce apoptosis. This suggests that NGFI-B might be a molecular target for the 
development of anticancer drugs that induce translocation of NGFI-B from the nucleus to 
mitochondria in order to inhibit growth and to induce apoptosis (Kolluri et al., 2003). Contrarily, 
agents that inhibit translocation of NGFI-B to the mitochondria would possibly prevent the cell 
death of neurons in neurodegenerative disorders. 
 
1.2 Nucleocytoplasmic Transport 
Selective transport between the nucleus and the cytoplasm is essential to sustain a distinctive 
composition of the two compartments. Regulation of the nucleocytoplasmic transport enables 
proteins, such as NGFI-B, to have divergent functions depending on the subcellular localization.  
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The bidirectional transport of macromolecules between the cytoplasm and the nucleus occurs 
through large, multiprotein structures named nuclear pores complexes (NPCs). Ions and small 
proteins (<40 kDa) can passively diffuse through NPCs, while passage of larger molecules are 
restricted to those having an NLS or NES. Several classes of NLS and NES exists and are 
recognized by components of separate pathways (Stewart, 2007). Different nuclear transport 
pathways imports or exports a specific range of macromolecules, but share many common 
features based on a series of protein interactions in which cargoes are recognized, translocated 
through NPCs, and released. The best understood pathway of nucleocytoplasmic transport is the 
classical nuclear import pathway (Figure 1.3), but alternative mechanisms are likely to exist 
(Lange et al., 2007). In the classical nuclear import pathway, a protein is imported by a 
heterodimeric import receptor consisting of importin β and importin α. Importin β mediates 
interactions with the nuclear pore complex, while the adaptor protein importin α directly binds 
the NLS (Gorlich et al., 1995). The classical NLSs contain one or two clusters of basic residues 
(Dingwall and Laskey, 1991; Robbins et al., 1991). Classical nuclear transport requires energy 
that is provided by a small Ras-family GTPase, Ran, which cycles between a GTP- and a GDP-
bound state (Bourne et al., 1990; Quimby and Dasso, 2003). Import receptors bind cargo in the 
cytoplasm in the absence of RanGTP and release cargo in the nucleus upon RanGTP binding 
(Figure 1.3) (Smith et al., 2002). 
 
 
Figure 1.3: The classical nuclear import cycle.  
Importin β is bound to the flexible autoinhibitory domain of importin α in the cytoplasm, thereby preventing the 
autoinhibitory domain from binding the NLS-binding pocket.  NLSs are then able to bind to importin α with high 
affinity. When RanGTP binds to importin β in the nucleus, the resulting conformational change leads to release of 
the autoinhibitory domain, which now can compete for binding to the NLS-binding pocket. This competition 
contributes to a low affinity of the NLS for importin α in the nucleus, and NLS cargo delivery is facilitated.  
The figure is from Lange et.al (2007). 
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1.3 The MAPK/ERK Kinase (MEK)/ ERK Pathway 
The MEK/ERK cascade (Figure 1.4) couples signals from cell surface receptors to transcription 
factors, and is known to phosphorylate the nuclear receptor NGFI-B (section 1.1) (Slagsvold et 
al., 2002). Depending upon the stimulus and cell type, this pathway can transmit signals resulting 
in the prevention or induction of apoptosis (Chang et al., 2003).  
 
Figure 1.4: The MEK/ERK pathway. 
The pathway activated by extracellular signaling via Ras 
begins with the MAP-kinase-kinase-kinase RAF, which 
activates the MAP-kinase-kinase MEK. MEK triggers 
the activation of the MAPK ERK by phosphorylating a 
threonine and a tyrosine in its activation loop. ERK 
phosphorylates numerous substrates at serine and 
threonine residues in all cell compartments. In the 
nucleus, ERK may phosphorylate transcription factors 
and thereby activate the transcription of immediate early 
genes. The resulting changes in gene expression and 
protein activity cause complex changes in cell behavior 
(Chang et al., 2003). The figure is modified from 
Alberts et al. (2002). 
 
 
The MAP kinase ERK is of great importance in the control of cell growth and differentiation, and 
is also involved in neuronal plasticity. Glutamate (section 1.4.1) activation of the MEK/ERK 
pathway via the N-methyl-d-aspartate receptor (NMDAR) (section 1.4.2) is involved in 
mammalian memory and learning (Bading and Greenberg, 1991; Kurino et al., 1995; Mao et al., 
2004; Perkinton et al., 2002; Platenik et al., 2000). However, the ERK activation during 
neuropathological over-stimulation of NMDARs may contribute to neuronal death in the adult 
brain (Jiang et al., 2000). The relevance of MEK/ERK pathways in neuronal cell survival was 
documented in PC12 pheochromocytoma cells where down-regulation of ERK mediated by NGF 
withdrawal led to apoptosis, whereas the activation of the ERK signaling pathway by NGF 
inhibited apoptosis (Xia et al., 1995b). Another growth factor, EGF, reduces the glutamate-
induced neuronal death in cerebellar granule neurons (CGN) (section 1.5.1) from fetal rats, as 
well as in other neuronal cells (Abe and Saito, 1992; Casper and Blum, 1995; Gunn-Moore and 
Tavare, 1998). EGF is shown to activate ERK2, and to inhibit apoptosis-induced translocation of 
NGFI-B from the nucleus to the mitochondria (Jacobs et al., 2004).  
Raf
MEK
ERK
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1.4 Glutamate-Induced Excitotoxicity 
The nuclear receptor NGFI-B is highly expressed in adult neurons and is shown to translocate to 
mitochondria in glutamate-exposed cerebellar granule neurons (CGN) (Jacobs et al., 2004). 
1.4.1 Glutamate as a Neurotoxin 
The amino acid L-glutamate is the principal excitatory neurotransmitter in the mammalian brain 
(reviewed in (Fonnum, 1984) where it is involved in plasticity, memory, and learning (Asztély 
and Gustafsson, 1996; Maren and Baudry, 1995). Fifty years ago, it was shown that excessive 
extracellular levels of glutamate for prolonged periods caused cell death (Lucas and Newhouse, 
1957). Excitotoxicity refers to the phenomenon in which over-activity of receptors responding to 
excitatory neurotransmitters injure neurons, and results in cell death (Olney, 1969). Death of 
adult neurons will induce irreversible damages, as the remaining cells will not have the ability to 
regenerate and compensate the loss. Excitotoxicity has been implicated in the pathogenesis of 
human neurodegenerative disorders such as Parkinson’s, Huntington’s, and Alzheimer’s diseases 
(Gardoni and Di Luca, 2006).  
 
Glutamate activates two families of receptors, namely the metabotropic receptors that are linked 
to G-proteins and second messenger signaling, and the ionotropic receptors that are ligand-gated 
ion channels. Among the latter are three subclasses designated by their selective agonists: kainic 
acid receptors, α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors, and 
NMDARs (Chen and Wyllie, 2006). NMDARs exhibit high permeability to calcium and a 
relatively slow rate of desensitization and deactivation, and, consequently, play a more prominent 
role in mediating excitotoxicity than the other glutamate receptors (Choi et al., 1988; Paoletti and 
Neyton, 2007). 
 
1.4.2 NMDAR-Mediated Neuronal Injury 
The NMDARs are heteromultimeric complexes of the subtypes NR1, NR2 and NR3. There are 
eight different NR1 subunits generated by alternative splicing from a single gene, four different 
NR2 subunits (A, B, C and D) and two NR3 subunits (A and B); the NR2 and NR3 subunits are 
encoded by six separate genes (Dingledine et al., 1999; Nishi et al., 2001; Sucher et al., 1995). 
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The consensus stoichiometry of NMDARs is that they are tetramers usually incorporating two 
NR1 and 2 NR2 subunits of the same or different subtypes (Dingledine et al., 1999). Such 
NMDARs requires the binding of both glutamate and the co-agonist glycine to be activated 
(Johnson and Ascher, 1987). Glycine binds to NR1 subunits while glutamate binds to NR2A-D 
subunits (Kuryatov et al., 1994; Laube et al., 1997). Mg2+ that is bound to a separate site in the 
receptor will loose its affinity when the neuron depolarizes, and the channel opens for ion flow 
(Figure 1.5) (Mori et al., 1992). In cells expressing NR3, this subunit will co-assemble with NR1 
and NR2 and form ternary NR1/NR2/NR3 tetrameric complexes (Sasaki et al., 2002). 
 
 
 
Figure 1.5: NMDA receptor organization.  
Schematic presentation of the NMDA receptor with overlaid tertiary structures for the NR1 and NR2 subunits and N-
terminal binding sites for glycine and glutamate. The figure is modified from Kristiansen et al. (2007). 
 
NMDAR-induced neuronal injury after prolonged exposure to glutamate will result from a 
massive influx of Ca2+ that trigger mitochondrial dysfunction, generation of reactive oxygen 
species (ROS), and cell death. The composition of NMDAR subunits affects neuronal 
vulnerability to glutamate. Changes in the relative expression levels and/or location of the NR2A 
and NR2B subunits is involved in the increased excitotoxicity acquired with age of neurons in 
culture (Brewer et al., 2007). 
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1.4.3 Intrinsic Apoptotic Pathways Involving Mitochondria 
A mild insult of glutamate toxicity will initiate neuronal apoptosis, while stronger insults results 
in necrosis. Apoptosis (Kerr et al., 1972) is associated with cell membrane blebbing, cell 
shrinkage, nuclear and cytoplasmic condensation, and DNA fragmentation and condensation. 
Finally, the cell is engulfed by macrophages and neighboring cells, thereby avoiding damage of 
the surrounding tissue. In contrast to the tightly organized process of apoptosis, necrosis is 
characterized by cell swelling, severe mitochondrial damage, and eventually cell lysis. Rupture of 
the cell will release intracellular contents that potentially could cause a damaging inflammatory 
response. Neurotransmitters can also be released, causing excitotoxicity to neighboring cells 
(Fink and Cookson, 2005). Regardless of differing morphology does apoptosis and necrosis have 
numerous cellular mechanisms in common, which led to the proposal of  the apoptosis-necrosis 
continuum model (Proskuryakov et al., 2003; Zeiss, 2003). 
 
Apoptotic stimuli leads to the release of pro-apoptotic proteins that reside in the inter-membrane 
space of mitochondria to the cytosol (Armstrong, 2006). The permeabilization of the outer 
mitochondrial membrane is normally prevented by Bcl-2 and several other members of the Bcl-2 
family of proteins. The regulatory effect of Bcl-2 on membrane permeability is due to the 
presence of four conserved sequence motifs known as Bcl-2 homology (BH) domains (Figure 
1.2) (Chan and Yu, 2004). Apoptogenic proteins, such as NGFI-B (section 1.1), can inactivate 
Bcl-2, resulting in the generation of pores that permeate the mitochondrial outer membrane 
(Figure 1.6) (Lin et al., 2004). The released proteins can propagate apoptosis either by activating 
a group of enzymes of the cysteine protease family known as caspases, or by acting in a caspase-
independent fashion. Caspase dependent factors include cytochrome c, a small heme-containing 
protein involved in electron transport and oxidative phosphorylation. Cytochrome c released to 
the cytoplasm will combine with a highly conserved protein known as apoptotic protease-
activating factor 1 (Apaf-1) and induce the ATP-dependent formation of an oligomeric complex 
known as the apoptosome (Cain et al., 2002). The apoptosome recruits and processes the crucial 
initiator caspase, caspase 9, which cleaves and activates downstream caspases, such as the 
effector caspase 3 (Jiang and Wang, 2000). The effector caspases will subsequently cleave a 
variety of cellular proteins, and thereby activate or inactivate them. These proteins will be 
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directly or indirectly responsible for the morphological and biochemical alterations in the 
apoptotic cell (Gogvadze and Orrenius, 2006).  
 
The mitochondrial flavoprotein AIF is the main mediator of caspase-independent apoptosis 
(Vahsen et al., 2004). AIF has a NADH oxidase activity and might participate in scavenging of 
reactive oxygen species (ROS) (Klein et al., 2002). Upon apoptosis, AIF translocates from the 
mitochondria to the nucleus where it participates in chromatin condensation and DNA 
fragmentation (Susin et al., 1999).  
 
 
 
 
 
Figure 1.6: Mitochondrial apoptosis.  
NGFI-B translocates from the nucleus 
to the mitochondria in response to 
apoptotic stimuli. The resulting 
conformational change of anti-
apoptotic Bcl-2 makes it pro-apoptotic. 
As a result, cytochrome c and AIF are 
released and apoptosis is induced (see 
text for details).  
 
1.5 Introduction to Experimental Systems 
1.5.1 Cerebellar Granule Neurons as an In Vitro Model for Neuronal Apoptosis 
Primary cultures of cerebellar granule neurons (CGN) are a popular in vitro model for studying 
neuronal apoptosis, as well as other aspects of neurobiology, in a very uniform population of 
neurons (95-98 % pure neuron cultures) (Figure 1.7) (Ciani and Paulsen, 1995). Glutamate 
(section 1.4.1) efficiently induces apoptosis in cultured CGN, which express all of the glutamate 
receptor subtypes including the NMDA receptor (section 1.4.2). The CGN express AIF (section 
AIF
Apoptosis
Cyt c
Cyt c
Pro-
caspase
9
Apaf-1
ATP
apoptosome
Bcl-2
NGFI-B
Caspase
9
Caspase cascade 
(effector caspases 3, 6, 7, 14)
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1.4.3), and translocation of NGFI-B (section 1.1) from the nucleus to the mitochondria has been 
demonstrated in this cell model  (Jacobs et al., 2004). 
 
 
Figure 1.7: Phase contrast micrograph of 14 days old untreated CGN. 
 
The cell bodies of CGN are located in the deepest layer of the tri-laminar cerebellar cortex with 
axons protruded up into the superficial molecular layer. The CGN are the largest homogenous 
neuronal population in the mammalian brain, constituting more than 90 % of the neurons in the 
cerebellum (Contestabile, 2002). The neurogenesis of granule cells is mainly postnatal, making 
them a suited source for primary neurons to be grown in vitro. In culture, the CGN will get 
altered connectivity by forming synapses with each other. This feature makes the CGN suitable 
for studies of neuronal toxicity in general, not only cerebellar toxicity. Glutamate toxicity peaks 
in CGN that have been maintained for 14 days in vitro, due to changes in the composition of 
NMDAR subtypes (section 1.4.2) (Xia et al., 1995a). As the CGN cultures mature, there is a shift 
between high expression of the NR2C subunit to a more predominant expression of NR2A and 
NR2B (Gerber and Vallano, 2006). 
 
The advantage of using CGN primary cultures instead of cell lines is that a primary culture has 
cells that are more similar to the cells in vivo. However, a disadvantage is that the CGN show low 
transfection efficiency (Ciani and Paulsen, 1995). Furthermore, microscopic examination of 
subcellular distributions within CGN are demanding, as the cells have nuclei that encompass 
most of the cell body, leaving a thin rim of cytoplasm. 
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1.5.2 CV-1 cells 
The CV-1 cell line was established in the early1960s from the kidney tissue of an adult male 
African green monkey (Cercopithecus aethiops) (Hopps et al., 1963). This cell line express 
NGFI-B, grows adherently to glass or plastic surfaces, and is easily transfected. The cells have a 
distinct nucleus and a large cytoplasm, and are therefore well suited for microscopic experiments 
studying protein distribution within cells.  
 
1.5.3 The Firefly Luciferin/Luciferase Reaction 
The luciferin/luciferase reaction is widely used as a sensitive method for monitoring intracellular 
ATP concentration. Luciferase from Phontinus pyralus, the most common species of North 
American fireflies, catalyze the formation of D(-)-luciferyl adenylate from D(-)-luciferin and 
ATP-Mg. The oxidation of the acyl adenylate by molecular oxygen leads to the formation of an 
enzyme bound product molecule in the excited state, which subsequently decays to the ground-
state oxyluciferin with the emission of light (Seliger et al., 1961). When ATP is the limiting 
factor in the luciferin oxidation reaction, the amount of light produced is proportional to the ATP 
concentration of the sample (Allue I, 1996). 
 
1.6 Aims of the Thesis 
1. To establish a luminometric ATP-assay with over-expressed luciferase from CV-1 
cells for validation of ATP-depletion in these cells. 
2. To determine whether nuclear import of NGFI-B in CV-1 cells is energy-dependent. 
3. To investigate the effect of a threonine 142 to alanine or glutamate mutation on the 
nuclear import of NGFI-B in CV-1 cells, and whether the nuclear import of NGFI-B 
is influenced by over-expression of dominant active or dominant negative ERK2. 
4. To examine the effect of MEK/ERK inhibition before and after glutamate exposure on 
CGN death. 
5. To investigate whether CGN is a suitable model for determination of neuronal NGFI-
B traffic for studies using a confocal microscope.
Materials and Methods 
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2 Materials and Methods 
2.1 CV-1 Cells 
2.1.1 Splitting CV-1 Cells 
CV-1 cells were grown in 175 cm2 flasks and were incubated at 37 ºC in 5 % CO2. Cells were 
split when confluent every 3 or 4 days. 
 
Splitting procedure: 
1. Remove medium. 
2. Wash with 2 ml trypsin-ethylenediaminetetraacetic acid (EDTA). 
3. Add 2 ml trypsin-EDTA and incubate at 37 ºC in 5 % CO2 for 10 min. 
4. Tap the flask and add 10 ml CV-1 medium (Table 2.1). 
5. Mix and dispense 1.5 ml cell suspension into culture flasks containing 20 ml CV-1 medium.  
 
Table 2.1: CV-1 cell culture medium with fetal bovine serum 
 Component Quantity  
    
 Fetal bovine serum (FBS) 50 ml  
 Sodium pyruvate (from 100x stock) 5 ml  
 Penicillin-Streptomycin (from 100x stock) 5 ml  
 Dulbecoos MEM (DMEM) 500 ml  
 
 
  
 
2.1.2 Transient Transfection of CV-1 Cells 
CV-1 cells were seeded at 5.4 x 103 cells / cm2 into culture dishes (21.5 cm2) to a volume of 3.3 
ml for later harvesting (section 2.1.4), and at 2.1 x 104 cells / cm2 into 4 well chambered cover 
glasses (1.7 cm2) to a volume of 1 ml for fluorescence recovery after photobleaching (FRAP) 
experiments (section 2.1.5). The cells were transfected by calcium phosphate precipitation 
(Graham and van der Eb, 1973) one day after seeding. 
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Transfection procedure: 
1. Mix equal amounts of N,N-bis-(2-hydroxyethyl)-2-aminoethanesulfonic acid (BES) buffered 
saline solution (BBS) (Table 2.2) and 0.25 M CaCl2 (in distilled water filter sterilized 
(0.2µm)). 
2. Add 10 µg DNA/ml (Table 2.3). 
3. Whirlmix 5+10 s and incubate for 20 min at room temperature. 
4. Add drop-wise 330 µl to culture dishes and 100 µl to 4 well plates. 
5. Incubate at 37 ºC with 5 % CO2 for two days (section 2.1.3 and 2.1.5). 
 
Table 2.2: BBS 
Component Final concentration Quantity 
 
BES 
 
50 mM 
 
5.333 g 
Na2HPO4 2 mM 0.134 g 
NaCl (5 M)  280 mM  28.0 ml 
MQ-H2O  ad 500 ml 
   
 
pH was adjusted to 6.75, 6.85, 6.95, 7.00, and 7.05 with NaOH and HCl. Solutions were filter 
sterilized (0.2 µm) and the most efficient BBS pH was determined by transfection and luciferase 
measurements (Moen, 2007).  
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               Table 2.3: Plasmids for transfections 
Gene product Plasmid Source Plasmid 
short name 
FRAP ATP-
assay 
firefly luciferase  prsv-luciferase Promega rsv-luc  1 µg/ml 
green fluorescent 
protein (GFP) 
pAd-GFP Kindly 
provided by 
Prof. Anne 
Carine 
Østvold, 
University of 
Oslo 
GFP 3 µg/ml  
GFP-tagged NGFI-B pNGFI-B-GFP Jacobs et.al 
(2004) 
NGFI-B-GFP 3 µg/ml  
GFP-tagged T142A-
NGFI-B 
pNGFI-
B(T142A)-
GFP 
Produced in 
the Prof. R.E. 
Paulsen 
laboratory 
NGFI-B-
T142A-GFP 
3 µg/ml  
GFP-tagged T142E-
NGFI-B 
pNGFI-
B(T142E)-
GFP 
Produced in 
the Prof. R.E. 
Paulsen 
laboratory 
NGFI-B-
T142E-GFP 
3 µg/ml  
ERK2 dominant 
active 
pCMV5 
ERK2-MEK 
1R4F 
Kindly 
provided by 
Dr. M. Cobb, 
University of 
Texas 
MEKERK2 5 µg/ml  
ERK2 dominant 
negative 
pCMV5 ERK2 
K52R 
Kindly 
provided by 
Dr. M. Cobb, 
University of 
Texas 
KRERK2 5 µg/ml  
none (empty 
expressor plasmid) 
pCMV neo Wilson et.al 
(1991)  
CMV 2 µg/ml or 7 µg/ml  9 µg/ml 
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Cells for ATP measurements (section 2.1.3) were transfected with the plasmids rsv-luc and 
CMV. Cells for FRAP experiments (section 2.1.5) were transfected with GFP, NGFI-B-GFP, 
NGFI-B-T142A-GFP, or NGFI-B-T142E-GFP. Certain NGFI-B-GFP-transfected cells were 
treated with EGF (5 ng/ml) for 10 min before FRAP. NGFI-B-T142A-GFP and NGFI-B-
T142E-GFP had replaced the threonine 142 residue in NGFI-B-GFP with alanine or glutamate, 
respectively, and was made by replacing nucleotides 510-695 of NGFI-B-GFP with the 
corresponding mutated nucleotide sequence from pNGFI-B-T142A and pNGFI-B-142E 
(Slagsvold et al., 2002). The threonine-to-alanine mutation was expected to mimic the 
dephosphorylated state of the residue, whereas the mutation to glutamate could mimic 
constitutive phosphorylation. Certain cells were also co-transfected with MEKERK2 (dominant 
(constitutive) active) or KRERK2 (dominant negative (inactive)). CMV was added to obtain a 
final concentration of 10 µg DNA/ml. 
 
2.1.3 ATP-Depletion  
Cells for ATP measurements (section 2.1.4) and FRAP (section 2.1.5) experiments were ATP-
depleted two days after transfection. NaN3 was added to inhibit cytochrome c oxidase in the 
electron transport chain, and cells were depleted of glucose to abolish glycolysis.  
 
ATP-depletion procedure: 
1. Aspirate CV-1 medium from culture dishes. 
2. Wash with, and add, 3.3 ml glucose-free CV-1 medium. 
3. Add NaN3 from a 0.3 M stock to a final concentration of 5 mM. 
4. Incubate for 2, 4, or 6 hrs at 37 ºC in 5 % CO2. 
 
2.1.4 Cell Harvest and ATP-Measurement 
Untreated or ATP-depleted non-transfected cells and cells transfected with rsv-luc were 
harvested, and ATP was measured, 2 days after transfection.  
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Harvesting procedure: 
1. Wash dishes twice with ice-cold phosphate buffered saline (PBS) (Table 2.15). 
2. Add 235 µl 0.1 % LUC with freshly added 0.5 M Dithiothreitol (DTT) (500:1) (Table 2.4), 
and incubate for 5 min at room temperature. 
3. Scrape off cells with a cell lifter and transfer to eppendorf tubes on ice. 
4. Centrifuge for 5 min at 16 000 x g at 4 ºC. 
5. Place tubes back on ice. 
 
The following exceptions were made from the harvesting procedure (listed in section 3.1): 
− Cells were harvested in 235 µl of boiling Milli Q (MQ)-H2O. The boiling water would 
lyse cells and denature proteins (Yang et al., 2002). 
− Solutions in the harvesting procedure were added trichloroacetic acid (TCA) to a 
concentration of 10, 5, 2.5, or 1.25 % (Berg-Johnsen et al., 1993), and cells were 
harvested. TCA is usually added to EDTA when used in protein precipitation. However, 
EDTA was not added because of its ability of to form complexes with Mg2+, which is 
required for the luciferin oxidation reaction. 
− Cell lysates were boiled for 15 min to denature proteins, and tubes were placed back on 
ice. 
 
Table 2.4: Cell harvest solutions 
Solution Component Final concentration Quantity 
    
DTT  DDT 500 mM 77.2 mg 
stock MQ-H2O  1.0 ml 
    
    
0.1 % 
LUC 
1 M trishydroxymethylaminomethane (Tris) 
adjusted to pH 7.8 with 1 M  2-(N-
morpholino)ethanesulfonic acid (MES) 
 
 
50 mM 
 
 
5.0 ml 
 Triton X-100 0.1 % 0.1 ml 
 MQ-H2O   ad 100 ml 
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ATP was measured as relative luciferase units (RLU) using an EG&G Berthold Lumat LB9507 
luminometer. To a 5 ml Sarstadt tube, 10 µl cell lysate supernatant from cells transfected with 
rsv-luc, and thereby expressing luciferase, and 140 µl of LUC-cocktail with no ATP were added 
to 50 µl of ATP-dilution (Table 2.5) or cell lysate supernatant from non-transfected cells. The 
tube was inserted in the luminometer, luciferin (Table 2.5) was dispensed (100 µl), and the 
emission of light was measured for 2 sec. A sample containing 10 µl cell lysate from luciferase 
transfected cells and 190 µl LUC-cocktail without ATP was measured as a negative control. 
 
Table 2.5: Solutions for ATP-measurements 
Solution Component Final 
concentration 
Quantity 
    
Luciferin Luciferin 1 mM 30.0 mg 
 MQ-H2O  100 ml 
    
    
 ATP 4 mM 240.0 mg 
LUC- 1 M Mg(CH3COO)2 20 mM 2.0 ml 
cocktail 1 M Tris adjusted to pH 7.8 with 1 M MES 83 mM 8.3 ml 
 MQ-H2O  ad 100 ml 
    
 
LUC-cocktail with no ATP was also prepared.  
A 10-fold dilution series of the LUC-cocktail in LUC-cocktail with no ATP was made. 
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2.1.5 Fluorescence Recovery after Photobleaching (FRAP) Experiments 
FRAP was developed in the 1970s by Axelrod and coworkers (Axelrod et al., 1976) and is a 
popular technique for investigating the mobility of proteins in living cells. By using a confocal 
laser-scanning microscope (CLSM), fluorescent molecules are photobleached in an area by a 
high-powered focused laser beam in FRAP experiments. The photobleached molecules lose 
their ability to emit fluorescence when exposed to repeated cycles of excitation and emission. 
Subsequent diffusion of surrounding non-bleached fluorescent molecules into the bleached area 
leads to a recovery of fluorescence, which is recorded at low laser power.  
 
CV-1 cells for FRAP experiments were split into 4 well chambered cover glasses (section 
2.1.1), transfected (section 2.1.2), and incubated for 2 days. The FRAP analysis was performed 
at room temperature with a Nikon C-1 confocal unit mounted on a TE 2000E inverted 
microscope run by EZ-C1 3.40 software with a 60x oil immersion objective. Cells were imaged 
with the 488 nm laser power set to minimum and 1.5 amps, with a small pinhole. Gain was set 
between 4.40 and 6.05 so that no pixels were saturated because some information is lost in 
saturated pixels. The pre-bleach image was used as a reference for the steady-state distribution 
of florescent molecules. Next, the cell nucleus was outlined and bleached by 15 repeated scans 
with the 488 nm laser power at 100 % and 8 amps and the pinhole set to open. After bleaching, 
the laser power was reset to pre-bleach values and the pinhole to small, and one image was 
taken of the whole cell every 22 seconds, to a total of 30 images. The images were analyzed in 
the EZ-C1 3.20 FreeViewer software to obtain pixel intensity values in analog-to-digital 
converter units (ADC-units). 
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2.2 Culture of Rat Cerebellar Granule Neurons  
Cerebellar granule neurons (CGN) were derived from 7 days old Wistar rats from Charles River 
Laboratories, Germany. CGN primary cultures are widely used to investigate the neurotoxic 
effects of various factors, and they have provided important information concerning mechanisms 
of cell death (Vaudry et al., 2003). The CGN requires chronic depolarization conditions to 
survive, and this is obtained by raising potassium concentrations from the in vivo concentration 
of 3.5-5.5 mM  to >20 mM (Gallo et al., 1987). This state of sustained excitation is believed to 
mimic in vivo conditions related to the formation of excitatory synapses from mossy fibers (one 
of the major inputs to the cerebellum) onto differentiating CGN (Contestabile, 2002). CGN 
cultures were prepared according to a modified version of the procedure by Gallo et al. (1987) 
(section 2.2.1-2.2.3). 
 
2.2.1 Coating of Culture Dishes with Poly-L-Lysine 
To obtain a better adhesion of the CGN to the culture dishes, the dishes were coated with poly-L-
lysine one day prior to preparation. 
 
Coating procedure: 
1. Remove 10 ml from a 500 ml bottle of autoclaved MQ water and transfer to a sterile bottle of 
poly-L-lysine (5 mg).  
2. Dissolve and transfer back into the 500 ml bottle.  
3. Put 4 cover glasses into culture dishes for CLSM imaging. 
4. Dispense 2 ml/ culture dish (21.5 cm2).  
5. Coat 10 culture dishes per 3 rat brains.  
6. Aspirate fluid after 30-60 min and allow drying over night.  
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2.2.2 CGN Preparation 
CGN preparation procedure: 
Required equipment was given in Table 2.6. The given amounts are for preparation of cell 
cultures derived from 40-80 rats. 
1. Transport the heads of decapitated rat pups to LAF-hood. 
2. Isolate cerebella with scissors and tweezers and transfer to a large petri dish containing 
solution 1 (Table 2.7). 
3. Remove meninges with tweezers and transfer cerebella to another large petri dish containing 
solution 1. 
4. Remove solution 1 and cut cerebella in two directions at right angles to each other with a 
scalpel. 
5. Add 10 ml solution 1 and transfer cerebella to a tube containing another 10 ml of solution 1. 
Centrifuge at 170 x g for 0.5 -1 min. 
6. Remove supernatant and resuspend pellet in 10 ml solution 2 (Table 2.7).  
7. Transfer cell suspension to a trypsination bottle and tighten cap loosely. Keep in a 37 ºC 
shaking water bath for 15 min. 
8. Collect cerebellar pieces with a Pasteur pipette and transfer to a tube containing 14 ml 
solution 4 (Table 2.7). Add solution 4 to a final volume of 50 ml and centrifuge at 170 x g for 
2 min. 
9. Remove supernatant and add the volume of 3 Pasteur pipettes of solution 3 (Table 2.7). 
Narrow the tip of a Pasteur pipette by passing it through a flame. Dissolve pellet carefully by 
pipetting 20 times up and down with the Pasteur pipette. Allow aggregates to settle for a few 
minutes. 
10. Remove upper part of the solution (free of clumps) and transfer to a tube containing 15 ml 
solution 5 (Table 2.7). 
11. Add 2 ml solution 3 to remaining cerebellar pieces and repeat step 10, making a narrower 
opening in the Pasteur pipette. 
12. If necessary, repeat steps 9-11. 
13. Centrifuge cell suspension at 140 x g for 7 min. 
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14. Remove supernatant and resuspend pellet in 10 ml cell culture medium with fetal bovine 
serum (Table 2.9). Transfer into a flask containing half of the calculated amount of medium. 
Remove 0.5 ml of cell suspension for cell count in a Bürcher chamber. Calculate the quantity 
of the medium to be added. The desired cell density is 1.2 x106 cells/ml.  
15. Mix well and distribute 3.3 ml per culture dish.  
16. Incubate at 37 ºC with 5 % CO2 for 7 days.  
 
 
Equipment was sterilized in the autoclave for 20 min at 121 ºC.  
 
Table 2.6: Equipment 
 
1 pair of scissors and 2 tweezers for dissection 
2 tweezers for removing of meninges 
6 Pasteur pipettes with filter 
1 trypsination bottle 
Glass bottles for solutions 1-5 and culture medium 
1 scalpel 
2 large petri dishes 
Three 50 ml plastic tubes 
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Five solutions (Table 2.7) were freshly made for each preparation of CGN.   
 
Table 2.7: Solutions 1-5 
 
Solution 1 
 
1.50 g Bovine serum albumin (BSA) 
4 ml MgSO4 (3.82 g/100 ml) 
50 ml Krebs-Ringer solutions 10x (Table 2.8) 
Distilled water ad 500 ml 
 
 
Solution 2 
 
 
25 mg trypsin 
100 ml solution 1 
 
 
Solution 3 
 
 
0.5 mg MgSO4 (3.82 g/100 ml) 
6.25 mg deoxyribonuclease I (DNaseI) 
26 mg Trypsin inhibitor 
Solution 1 ad 50 ml 
  
 
Solution 4 
 
 
16 ml solution 3 
100 ml solution 1 
 
 
Solution 5 
 
 
320 µl CaCl2 (1.20 g/100 ml) 
320 µl MgSO4 (3.82 g/100 ml) 
40 ml solution 1 
 
 
The solutions were filter sterilized (0.2 µm). 
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Table 2.8: Krebs-Ringer solution (10x) 
Component Final concentration Quantity 
   
Phenol red 0.3 mM 50 mg 
KH2PO4 10 mM 0.83 g 
KCl 50 mM 1.80 g 
Glucose 0.14 M 12.85 g 
NaCl 1.21 M 35.35 g 
NaHCO3 0.25 M 10.70 g 
Distilled water  ad 500 ml 
   
 
Krebs-Ringer solution was stored in a refrigerator, and had a shelf life of 5-6 months. 
 
 
Table 2.9: CGN culture medium with fetal bovine serum 
Component  Final concentration Quantity 
   
Heat inactivated fetal bovine serum ~10 %                        50 ml 
Gentamicin sulfate 90.9 µg/ml                        50 mg 
Glutamine 1.8 mM                      146 mg 
KCl  25.5 mM  825 mg* 
Basal Medium Eagle (BME)                       500 ml 
*5.4 mM is already present in the medium 
 
KCl, glutamine, and gentamicin sulfate were added to 30 ml medium removed from a sterile 
bottle of 500 ml BME.  The solution was filter sterilized (0. 22 µl) back into the bottle. Heat 
inactivated fetal bovine serum (30 min in 56 ºC water bath) was added. 
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2.2.3 Prevention of Non-Neuronal Cell Growth 
Cytosine β-D-arabino-furanoside (Ara-C) was added to the cultures 16-20 hrs after preparation to 
inhibit proliferation of non-neuronal cells. 
 
Procedure for adding Ara-C: 
Dissolve 1 mg Ara-C in 10 ml cell culture medium with fetal bovine serum and filter sterilize 
(0.2 µm). Add 83µl/ 21.5 cm2 dish to obtain the final concentration of 10 µM.  
 
2.3 Exposure of Cultured Cerebellar Granule Neurons 
Cultured CGN were incubated with MEK inhibitor U0126 (sections 2.3.1 and 2.3.4) and EGF 
(section 2.3.2), and exposed to glutamate (section 2.3.3), 7 days after preparation.  
 
2.3.1 Pre-Incubation with MEK Inhibitor U0126 
The U0126 stock was added to the culture dishes to a final concentration of 10µM. The dishes 
were incubated at 37 ºC with 5 % CO2 for 1 h, followed by glutamate or buffer control exposure.  
 
U0126 stock (10 mM): 
Add 234 µl dimethyl sulfoxide (DMSO) to 1 mg U0126. Store at -20 ºC. 
 
2.3.2 Pre-Incubation with Epidermal Growth Factor 
The CGN were pre-incubated in a pre-incubation solution consisting of Locke’s solution with or 
without EGF (5 ng/ml). 
Cells later exposed to glutamate were pre-incubated in Locke’s solution without magnesium 
(Table 2.10), whereas buffer controls were pre-incubated in Locke’s solution with magnesium 
(Table 2.11). 
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Pre-incubation procedure: 
1. Remove cell medium. 
2. Add 1 ml pre-incubation solution, swirl, and aspirate. 
3. Add 2 ml pre-incubation solution. 
4. Incubate for 15 min at room temperature. 
 
 
   Table 2.10 Locke’s solution without magnesium 
Component Final concentration Quantity 
   
CaCl2 2.3 mM 0.34 g 
NaHCO3 3.6 mM 0.30 g 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid (HEPES) (pH 7.4) 
 
5.0 mM 
 
1.19 g 
KCl 5.6 mM 0.42 g 
Glucose 5.6 mM 1.00 g 
NaCl 154.0 mM 9.00 g 
Distilled water   ad 1000 ml 
   
 
Adjust pH to 7.4. 
 
 
    Table 2.11: Locke’s solution with magnesium 
Component Final concentration Quantity 
   
MgCl2 x 7H2O 1.2 mM 0.24 g 
Locke’s solution without magnesium  1000 ml 
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2.3.3 Glutamate or Buffer Exposure 
After pre-incubation, cells were exposed to glutamate or physiological buffer. Locke’s solution 
with (Table 2.11) or without (Table 2.10) magnesium was used as a physiological exposure 
buffer. 
 
Exposure procedure: 
1. Remove cell medium through aspiration. 
2. Add 1 ml exposure solution (Table 2.12), swirl, and aspirate. 
3. Add 2 ml exposure solution. 
4. Incubate for 15 min at room temperature. 
5. Remove exposure solution. 
6. Add 1 ml cell culture medium without serum (Table 2.13), swirl, and aspirate. 
7. Add 2 ml cell culture medium without serum. 
8. Incubate at 37 ºC with 5 % CO2 for 2 hrs for fixing (section 2.5.1) and immunostaining 
(section 2.5.2). 
9. Incubate at 37 ºC with 5 % CO2 for 24 hrs for detection of cell death (section 2.4) 
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Table 2.12: Exposure solutions 
 
 
Table 2.13: Cell culture medium without serum 
Component Final concentration Quantity 
   
Gentamicin sulfate 100 µg/ml 50 mg 
Glutamine 2 mM 146 mg 
KCl 27 mM 825 mg 
BME  500 ml 
   
 
10 mM glutamate stock 
  
Glutamate 1.690 mg  
Distilled water 1 ml  
Store at -20 ºC   
   
1 mM glycine stock   
Glycine  0.075 mg  
Distilled water 1 ml  
Store at -20 ºC   
   
   
Glutamate exposure solution 
  
Lockes solution without magnesium 
  
Glycine 10 µM 
 
Glutamate 100 µM 
 
 
  
Buffer exposure solution 
  
Lockes solution with magnesium 
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Add KCl, glutamine, and gentamicin sulfate to 30 ml medium removed from a sterile 500 ml 
bottle of BME. Filter sterilize (0. 22 µm) back into the bottle. 
 
2.3.4 Post-Incubation with MEK Inhibitor U0126  
The MEK inhibitor U0126 was added 4 or 6 hrs after glutamate exposure. 
 
Post-incubation procedure: 
1. Add U0126 stock to the CGN culture dishes to a final concentration of 10 µM. 
2. Incubate at 37 ºC with 5 % CO2 for 1 h.  
3. Add 1 ml cell culture medium without serum, swirl, and aspirate. 
4. Add 2 ml cell culture medium without serum. 
 
2.4 Detection of Cerebellar Granule Neuron Death 
24 hrs after exposure, dying cells were detected by trypan blue staining. Trypan blue does not 
traverse the cell membranes of living cells, but is absorbed when the dying cells loose membrane 
integrity. In consequence, apoptotic and necrotic cells are shown in a distinct blue color under a 
microscope. 
 
Trypan blue staining procedure:  
1. Aspirate cell medium from the dishes until there is 1 ml left in the dish. 
2. Add 250 µl trypan blue staining solution (Table 2.14). 
3. Incubate at 37 ºC with 5 % CO2 for 30 min. 
4. Remove staining solution. 
5. Count stained (dead) and unstained (viable) cells under a microscope. 
6. Determine the percentage of dead cells. 
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Table 2.14: Solutions for trypan blue staining 
 
Trypan blue stock 
  
Trypan blue 1 g  
Distilled water 50 ml  
Heat until boiling while swirling. Cool at room temperature and filter. Keep at room 
temperature.  
   
NaCl stock    
NaCl 1.8 g  
Distilled water 100 ml  
Keep at room temperature   
   
Trypan blue staining solution   
Trypan blue stock (2 %) 125 µl x number of dishes  
NaCl Stock (1.8 g/ 100 ml) 125 µl x number of dishes  
   
 
 
2.5 Immunofluorescence Staining of Cerebellar Granule Neurons 
NGFI-B and AIF in CGN were immunostained with specific primary antibodies followed by 
fluorescent secondary antibodies for visualization under a CLSM microscope.  
 
2.5.1 Fixing 
Cells were fixed 2 hrs after exposure to preserve cells for analysis and storage. Paraformaldehyde 
(PFA) was used as a protein cross linking fixative.  
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PFA fixing procedure: 
1. Remove cell media from the dishes. 
2. Wash with PBS (Table 2.15). 
3. Add 2 ml freshly made 4 % PFA in PBS. 
4. Incubate at room temperature for 2, 5 or 10 min. 
5. Wash 3 x 5 min with PBS. 
6. Add 2 ml PBS and store at 4 ºC. 
 
Table 2.15: PBS 
Component Final concentration Quantity 
   
KH2PO4 1.5 mM 0.24 g 
KCl 2.7 mM 0.20 g 
Na2HPO4 6.5 mM 1.44 g 
NaCl 137.0 mM 8.01 g 
Distilled water  ad 1000 ml 
   
 
Adjust pH to 7.4 and autoclave.  
 
2.5.2 Staining 
Staining of the cells was performed as soon as possible after fixing. Two sets of antibodies were 
used: a primary antibody against the antigen of interest, and a secondary, fluorophore-coupled 
antibody, that recognized the primary antibody. The fluorescent dye 4’, 6-diamidino-2-
phenylindole (DAPI) was used to stain DNA in order to visualize cell nuclei.  
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Immunofluorescence procedure for CLSM imaging: 
1. Remove PBS from culture dishes. 
2. Add 50 µl pre-incubation solution (Table 2.16) for permeabilization and blocking onto 
parafilm. 
3. Place one cover glass on the pre-incubation droplet (cells facing down). 
4. Incubate at room temperature for 1 h. 
5. Wash 3 times with PBS by dipping the cover glass into 3 beakers containing PBS. 
6. Add 50 µl primary antibody solution (Table 2.16) onto parafilm. 
7. Place the cover glass on the droplet. 
8. Incubate at 4 ºC over night in a moist container. 
9. Wash 3 times with PBS. 
10. Add 50 µl secondary antibody solution (Table 2.16) onto parafilm. 
11. Place the cover glass on the droplet. 
12. Incubate in the dark at room temperature for 1 h. 
13. Wash 3 times in PBS. 
14. Add 50 µl DAPI working solution (Table 2.18) onto parafilm. 
15. Place the cover glass on the droplet. 
16. Incubate in the dark at room temperature for 10 min. 
17. Wash once with PBS. 
18. Mount 4 cover glasses on one object glass with 10 µl of FluorSave™ mounting medium for 
each cover glass.  
19. Dry over night, seal with nail polish, and store in the dark. 
20. Image in a CLSM. 
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Table 2.16: Immunofluorescence solutions 
Component Final concentration Quantity 
   
Pre-incubation solution   
5 % Triton X-100 (in PBS) 0.5 % 2.0 ml 
Normal mouse serum 10 % 2.0 ml 
PBS  16.0 ml 
Make 4 ml aliquots. Store at -20ºC. 
   
Incubation solution   
5 % Triton X-100 0.5 % 2.0 ml 
Normal mouse serum 3 % 600 µl 
PBS  17.4 ml 
Make 4 ml aliquots. Store at -20ºC. 
   
Primary antibody solution   
Dilute primary antibody 1:100 in incubation solution. 
   
Secondary antibody solution   
Centrifuge secondary antibody at 16 060 x g and 4 ºC, for 10 min. 
Dilute CyTM 3 and Fluorescein isothiocyanat (FITC) 1:200 in incubation solution. 
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Table 2.17: Antibodies 
 
Primary antibodies 
Nur-77 antibody (anti mouse nur-77 rabbit polyclonal IgG) 
AIF antibody (anti mouse AIF goat polyclonal IgG) 
 
Secondary antibodies 
Cy™ 3-conjugated mouse anti-rabbit IgG  
FITC -conjugated mouse anti-goat IgG 
 
 
Table 2.18: Solutions for DAPI staining 
Component Quantity  
   
DAPI stock (1 mg/ml)   
DAPI 1.0 mg  
Physiological (0.9 % NaCl) saline  1.0 ml  
   
DAPI working solution (10 000 x dilution)   
DAPI stock (1 mg/ml) 0.2 µl  
5 % Triton X-100 stock 40.0 µl  
PBS (Table 2.15) 2.0 ml  
   
 
2.6 Graphing and Statistical Analysis 
GraphPad Prism 4 software from GraphPad Software Inc., San Diego, USA, was used for 
graphing, while Sigma Stat 3.2 software from SPSS Inc., Chicago USA, was used for statistical 
analyses of data. An unpaired t-test was used for comparison of means of two groups. Multiple 
comparisons of means were analyzed by one way analysis of variance (ANOVA) and the Holm-
Sidak method. If equal variance failed, multiple comparisons of medians were analyzed by 
Kruskal-Wallis one way ANOVA on ranks with Dunn’s method. P < 0.05 was considered 
significant. Error bars of means in figures indicate standard error (SE). 
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3 Results 
3.1 ATP-Depletion 
3.1.1 Establishment of a Luminometric ATP Assay with Over-Expressed 
Luciferase in Cell Lysates for Validation of ATP-Depletions 
To verify that cells used in FRAP experiments (section 3.2.1) were ATP-depleted, an assay for 
measuring ATP in a luminometer was established. CV-1 cells were transfected with the plasmid 
rsv-luc (section 2.1.2) to express the luciferase enzyme required in the luciferin oxidation 
reaction (section 1.5.3). The cells were harvested, and ATP from non-transfected cells or ATP-
dilutions was measured in the luminometer (section 2.1.3). To correct for ATP present in the cells 
that expressed the luciferase enzyme, these cells were separately measured twice, and the mean 
value was subtracted as a negative control within every experiment. The values obtained could 
not be directly compared between all experiments because of varying concentrations of luciferase 
in cell lysates, and thereby differences in RLU measurements for the same amount of ATP. 
 
Cell lysate from non-transfected cells, 50 µl, was measured with 10–40 µl of cell lysate from rsv-
luc transfected cells to establish the lowest optimal amount of luciferase-containing cell lysate to 
be used. A small amount of rsv-luc containing cell lysate would reduce background ATP and 
substances that could affect the luciferin/luciferase reaction. The data are presented in Table 3.1. 
 
 
Table 3.1: Luminometer measurements with varying volumes of cell lysate from cells transfected 
with rsv-luc. 
Cell lysate from non-transfected cells (50 µl) was measured in the luminometer with cell lysate from 
luciferase-expressing cells to determine the minimum amount of luciferase containing cell lysate required 
for the ATP measurements (n=1). 
 
Cell lysate from rsv-luctransfected cells (µl) Signal (RLU) 
40 703 
20 422 
10 234 
5 60 
0 65 
Results  
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The minimum amount of luciferase-containing cell lysate that provided a measurement above the 
background signal was 10 µl, and this amount was therefore used in the subsequent experiments.  
 
To determine the linear range in the luminometer, a ten-fold dilution series of ATP, ranging from 
2.4 mg/ml to 2.4 x10-5 mg/ml, was the initial measurement of every experiment.  A dilution in the 
linear range would later be used as an internal standard in the ATP measurements. The data are 
presented in Figure 3.1. 
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Figure 3.1: Luminometer measurements of a 10-fold dilution series of ATP.  
Rsv-luc transfected cells were harvested to provide the luciferase enzyme required for measurements of ATP 
dilutions in the luminometer. The RLU-signal in samples with 10 µl from this cell extract and 50 µl of a 10-fold 
dilution series of ATP was measured. (A) The data were from 1 representative experiment out of 13 independent 
experiments and were subtracted the negative control value of 701 RLU. (B) Measurements of the 2.4 x10-2/10-3/10-4 
mg/ml ATP dilutions were plotted to display the linearity in this range, with regression plotted in red (r2=0.9999). 
The data were average from 3 representative experiments (RLR-values were comparable) out of 13 independent 
experiments. 
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RLU values from measurements of the 2.4 x10-3 mg/ml ATP dilution were in the linear range. 
Consequently, this dilution was used as an internal standard in subsequent experiments to 
determine if there were substances present in the cell lysate that could affect the 
luciferin/luciferase reaction. Samples consisting of cell lysate from non-transfected cells (50 µl) 
and/or varying volumes of the 2.4 x10-3 mg/ml ATP dilution were measured in the luminometer 
as displayed in Table 3.2. Cell lysate from rsv-luc transfected cells (10µl) was added to all 
samples to provide the luciferase enzyme. Loss of signal was calculated from the measurement of 
the 2.4 x10-3 mg/ml ATP dilution by it self or multiplied by two to four, and added to the 
measurement of the cell lysate from non-transfected cells only. 
 
Table 3.2: Luminometer measurements of varying volumes of the 2.4 x10-3 mg/ml ATP dilution.  
Cell lysate from non-transfected cells and/or varying volumes of the 2.4 x10-3 mg/ml ATP dilution was measured in 
the luminometer with 10 µl of cell lysate containing the luciferase enzyme. Data were from 1 representative 
experiment out of 6 independent experiments and were subtracted the negative control of 610 RLU. 
 
Cell lysate from non-
transfected cells (µl) 
ATP dilution  
(2.4 x10-3 mg/ml) (µl) 
Signal  
(RLU) 
Loss of signal  
(%) 
50 0 2305  
0 50 1633  
50 50 2591     35 
50 100 2502      55 
50 150 3328      56 
50 200 3746       58 
 
 
The results did not demonstrate an increase of signal corresponding to the amount of ATP added, 
thus indicating that the cell lysate was quenching the signal. The signal was reduced by 35-58 % 
from the predicted RLU values. In order to reduce the activity of ATPases or other factors that 
reduced the RLU signal, the non-transfected cells were harvested in solutions containing TCA 
before measurements. The effects on the quenching of the RLU-signal after harvesting the cells 
in boiling water or boiling of the cell lysate were also assayed. Cells expressing the luciferase 
enzyme were harvested according to the conventional protocol. 
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Non-transfected cells were harvested in TCA to precipitate proteins, as indicated in Table 3.3, 
and measured in the luminometer. 
 
Table 3.3: Luminometer measurements of cell lysate from non-transfected cells harvested in 
varying concentrations of TCA.  
Non-transfected cells were harvested in solutions containing TCA in order to precipitate proteins that 
could reduce the RLU signals. From the resulting cell lysate, 50 µl was measured with 10 µl of cell 
lysate from rsv-luc transfected cells that expressed the luciferase enzyme (n=1). The negative control 
(825 RLU) was not subtracted in the middle column, as this would result in negative RLU values. The 
negative control was subtracted in the right column, and negative RLU values were set to 0. 
 
 
TCA  
(%) 
Signal  
(RLU) 
Signal (RLU) 
 ÷ negative control 
0 2551 1726 
10.00 65 0 
5.00 258 0 
2.50 399 0 
1.25 151 0 
 
 
Cell harvesting with TCA lowered the RLU signals of non-transfected cell lysates to negative 
values after subtraction of the negative control. Hence, harvesting of cells with TCA was not a 
suitable method for reducing the activity of factors quenching the RLU signal. Boiling of the cell 
lysate from non-transfected cells could possibly reduce quenching as boiling MQ-H2O would 
lysate cells and denature proteins. Non-transfected cells were harvested in boiling MQ-H2O and 
measured alone, or with varying volumes of the 2.4 x10-3 mg/ml ATP dilution, as specified in 
Table 3.4. 
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Table 3.4: Luminometer measurements of varying volumes of a 2.4 x10-3 mg/ml ATP dilution with cell 
lysate from non-transfected cells harvested in boiling water.  
Non-transfected cells were harvested in boiling MQ-H2O to denature proteins that possibly were quenching 
the RLU signal. The cell lysate was measured separately, or with an ATP-dilution. Luciferase was provided 
from 10 µl of cell lysate from rsv-luc transfected cells. The data were from 1 representative experiment out of 
2 independent experiments. 
 
Cell lysate from non-
transfected cells (µl) 
ATP Dilution with  
2.4 x10-3 mg/ml (µl) 
Signal 
(RLU) 
Loss of signal  
(%) 
50 0 1448  
0 50 720  
50 50 1496 31 
50 100 1573 46 
 
 
The results demonstrated a reduction of RLU signals if compared to the RLU value measured 
from the cell lysate from non-transfected cells by it self added to the value measured from the 
ATP-dilution by it self. However, the 31 % and 46 % loss of signals in this experiment 
represented a small improvement from the 35-58 % of signals that were lost in the measurements 
of cell lysates that were harvested without boiling water (Figure 3.2). This result indicated that 
the level of substances that quenched the RLU signal could to some extent be reduced by boiling. 
Consequently, boiling of the cell lysate after conventional harvesting in order to denature proteins 
and thereby inhibit quenching was also assayed. After boiling, the cell lysate was measured in the 
luminometer alone or with the 2.4 x10-3 mg/ml ATP dilution. The results are presented in Table 
3.5. 
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Table 3.5: Luminometer measurements of varying volumes of a 2.4 x10-3 mg/ml ATP dilution with boiled 
cell lysate from non-transfected cells.  
Non-transfected cells were harvested and boiled to denature proteins that could inhibit the luciferin/luciferase 
reaction. The cell lysate, and 10 µl of cell lysate containing luciferase, were measured alone or with an ATP 
dilution. Data were from 1 representative experiment out of 3 independent experiment, and were subtracted the 
negative control of 610 RLU. 
 
Volume of cell lysate from 
non-transfected cells (µl) 
Volume of the 2.4 x10-3 
mg/ml ATP dilution (µl) 
Signal 
(RLU) 
Loss of signal  
(%) 
50 0 2305  
0 50 1533  
50 50 2591 18 
50 100 2502 6 
50 150 3328 21 
50 200 3746 22 
 
 
Boiling of the cell lysate from non-transfected cells did not provide the increase in RLU values 
that could be predicted from the addition of ATP to the cell lysate from the non-transfected cells. 
However, the loss of signal was lower than in the measurements of cell lysates that were not 
boiled (Table 3.2). The reduction of RLU signals is displayed in Figure 3.2. 
 
 
 
 
Figure 3.2: Loss of RLU signals in measurements of a  
2.4 x10-3 mg/ml ATP dilution.  
Different volumes of a 2.4 x10-3 mg/ml ATP dilution were 
added to cell lysates from a conventional harvest of non-
transfected cells (Table 3.2) or lysates from non-transfected 
cells that were boiled during or after harvesting (Table 3.4 
and Table 3.5). Reduction of predicted signal after adding of 
ATP was calculated in the given tables and is displayed as 
mean with SE. 
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Boiling of the cell lysate that was harvested from non-transfected cells reduced the loss of signal, 
thus, the method was used in subsequent experiments. 
 
3.1.2 ATP-Depletion of CV-1 Cells 
CV-1 cells were ATP-depleted by incubation for 2, 4, 6, and 16 hrs in a glucose–free cell 
medium supplemented with NaN3 (section 2.1.3). Cells were harvested and cell lysates were 
boiled and measured in the luminometer (section 2.1.4). The results are displayed in Table 3.6. 
 
 
Table 3.6: Luminometer measurements of cell lysate from ATP-depleted cells.  
CV-1 cells were ATP-depleted in glucose-free medium supplemented with NaN3. Cells were harvested 
and cell lysate was boiled and measured in a luminometer. Data were from 1 representative experiment 
out of 3 independent experiments. 
 
Depletion time Signal (RLU) Percent of non-depleted 
0 hrs 1620 100 
2 hrs 1431 88 
4 hrs 1362 84 
6 hrs 204 13 
16 hrs 27 2 
 
 
The results showed a time-dependent decrease in ATP. Addition of internal standard in depleted 
cells showed a linear increase in RLU as in non-depleted cells (not shown), adding evidence to 
the linearity of the assay. Cells incubated for 16 hrs in glucose-free medium supplemented with 
NaN3 had a 98 % loss of RLU signal. However, when culture dishes that contained these cells 
were viewed under a microscope, few or no cells were attached to the plastic. In contrast, the 
cells depleted for 6 hrs showed normal morphology and were still attached to the plastic. The 6 
hrs of incubation was therefore used to obtain efficiently reduced ATP-levels in cells in 
subsequent experiments.  
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3.2 Nuclear Import of NGFI-B in CV-1 Cells 
3.2.1 Energy Requirements for Transport of NGFI-B from the Cytoplasm into the 
Nucleus 
The nuclear receptor NGFI-B contains two NLSs (Hsu et al., 2004), and is consequently a 
candidate for energy dependent nuclear import pathways (section 1.2). The effect of ATP-
depletion on nuclear import of NGFI-B was assayed in order to determine if the import was 
energy-dependent. CV-1 cells were transfected with GFP-tagged NGFI-B or GFP, and FRAP 
experiments were performed. The distribution of the fluorescent proteins in the CV-1-cells is 
displayed in Figure 3.3. 
 
 
 
Figure 3.3: Cells transfected with NGFI-B-GFP or GFP alone. 
CV-1 cells were transfected with NGFI-B-GFP or GFP to perform FRAP experiments. Cells were visualized in a 
CLSM. (A) The majority (80-90 %) of cells expressing NGFI-B-GFP had a higher concentration of fluorescent 
proteins in the nucleus than in the cytoplasm. (B) Some cells (10-20 %) had an even concentration of fluorescence in 
both cellular compartments, and these cells were selected for FRAP. (C) The concentration of GFP was evenly 
distributed between the nucleus and the cytoplasm. 
 
 
 
The micrographs demonstrated a higher concentration of NGFI-B-GFP in the nucleus compared 
to the cytoplasm in the majority of CV-1 cells (80-90 %, data not shown), while the concentration 
of GFP was similar in both compartments. The NGFI-B-GFP-expressing cells that were visually 
selected for FRAP had a distribution of fluorescence that was similar to that of GFP (10-20 %, 
data not shown). 
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Nuclear FRAP (section 2.1.5) was measured by live cell imaging of CV-1 cells transfected with 
NGFI-B-GFP or GFP (section 2.1.2). GFP has a molecular weight of 27 kDa, and was expected 
to passively diffuse through the NPCs which usually only hinder molecules larger that 40 kDa. 
GFP was therefore used as a control for energy independent nuclear import in cells. FRAP was 
also performed on the nuclei of transfected CV-1 cells that were ATP-depleted in a glucose free 
medium supplemented with NaN3 for 6 hrs (section 2.1.3). The initial slopes (0-22 s.) of the 
recoveries were calculated in order to quantify nuclear import and to minimize the impact of 
nuclear export. After photobleaching, the nuclear export was expected to play an increasing part 
in obtaining the equilibrium of fluorescence between the nucleus and the cytoplasm, as there 
would be increasingly more fluorescent molecules in the nucleus that could be exported. The 
results are presented in Figure 3.4. 
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Figure 3.4: Nuclear fluorescence recovery after photobleaching of cells transfected with NGFI-B-GFP or GFP, 
with or without ATP-depletion.  
CV-1 cells were transfected with NGFI-B-GFP (1) or GFP (2) and FRAP was performed on cell nuclei. FRAP was 
also performed after ATP-depletion of cells to investigate whether the nuclear import of NGFI-B was energy-
dependent. Slopes from 0-22 s. were displayed as a measure of nuclear import (export contributed negligible) (b). 
Data from two independent experiments were displayed as mean with SE (n=9). 
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The results demonstrated a reduced import of NGFI-B-GFP (approximately 30 % reduction) in 
the nucleus of ATP-depleted cells, compared to non-depleted cells in the first 22 s. after 
bleaching. The nuclear import of GFP was approximately equal in the presence and absence of 
ATP (reduced by less than 10 %).  
 
3.2.2 Effects of EGF or Phosphorylation of Threonine 142 on Nuclear Import of 
NGFI-B-GFP 
Translocation of NGFI-B from the nucleus to mitochondria is demonstrated to induce apoptosis 
(Li et al., 2000). The growth factor EGF activates ERK2 which phosphorylates Thr 142 in the 
amino terminal of NGFI-B (Slagsvold et al., 2002), and is shown to reduce mitochondrial 
association of NGFI-B (Jacobs et al., 2004). It was therefore interesting to investigate whether 
phosphorylation of Thr 142 in NGFI-B-GFP increased nuclear import of the nuclear receptor. 
The 142 threonine residue was mutated to alanine to block phosphorylation of this residue 
(NGFI-B-T142A-GFP), or to glutamate to mimic a constitutive phosphorylation (NGFI-B-
T142E-GFP). CV-1 cells were transfected with NGFI-B-GFP, NGFI-B-T142A-GFP, or NGFI-B-
T142E-GFP (section 2.1.2) and FRAP (section 2.1.5) was performed.  
 
No changes of subcellular distribution of NGFI-B-GFP with or without Thr mutations were 
detected by a visual assessment (data not shown). The majority of the cells (80-90 %, data not 
shown) had a higher concentration of fluorescent proteins in the nucleus compared to the 
cytoplasm, while a minority (10-20 %, data not shown) of cells had a more similar concentration 
in both compartments (such as NGFI-B-GFP in Figure 3.3). Cells with a slightly more 
fluorescent nucleus than cytoplasm were visually selected for photobleaching. The nuclear 
fluorescence recovery after photobleaching was assayed and plotted in Figure 3.5. The results 
were presented as overall recovery and as the slope of the first 22 seconds after photobleaching. 
The initial slopes of the recoveries were calculated in order to quantify nuclear import and to 
minimize the impact of nuclear export (section 3.2.1). 
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Figure 3.5: Recovery of nuclear fluorescence after photobleaching in cells transfected with NGFI-B-GFP, 
NGFI-B-T142A-GFP, and NGFI-B-T142E-GFP.  
CV-1 cells were transfected with NGFI-B-GFP, NGFI-B-T142A-GFP (to block phosphorylation), and NGFI-B-
T142E-GFP (to mimic the phosphorylated state of Thr 142). The effect of the mutations on nuclear import of NGFI-
B was investigated by nuclear FRAP. The slopes from 0-22 s after photobleaching were displayed as a measure of 
nuclear import. Data from two independent experiments were plotted as mean (a) or displayed as mean with SE (b) 
(n=8 or 9). 
 
The results demonstrated that a 142 threonine-to-alanine mutation that blocked phosphorylation 
of this residue slightly increased the nuclear import of NGFI-B-GFP after photobleaching (~10 % 
increase). The nuclear import of NGFI-B with a 142 threonine that was mutated to glutamate to 
mimic phosphorylation was reduced by approximately 25 %. 
 
To determine the steady state distribution of NGFI-B, NGFI-B-T142A-GFP, and NGFI-B-
T142E-GFP before FRAP, the ratios of nuclear fluorescence to fluorescence in the cytoplasm 
were calculated. The results are displayed in Figure 3.6. 
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Figure 3.6: Pre-bleach ratio of nuclear to cytoplasmic fluorescence. 
CV-1 cells were transfected with NGFI-B-GFP, NGFI-B-T142A-GFP (to block phosphorylation), and NGFI-B-
T142E-GFP (to mimic phosphorylation of Thr 142). The effects of these mutations on the ratio of nuclear to 
cytoplasmic fluorescence were calculated. The data from two independent experiments were displayed as mean with 
SE (n=8-9). 
 
 
Cells transfected with NGFI-B-GFP displayed the highest ratio of nuclear to cytoplasmic 
fluorescence while cells transfected with NGFI-B-T142E-GFP had the lowest. 
 
The results in Figure 3.5 and Figure 3.6 demonstrated an opposite effect of what was 
hypothesized. FRAP was therefore performed on CV-1 cells transfected with NGFI-B-GFP and 
treated with EGF, in order to determine whether EGF promoted nuclear import of NGFI-B in 
these cells. The results are presented in Figure 3.7. 
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Figure 3.7: Nuclear recovery of fluorescence after photobleaching in cells that were transfected with NGFI-B-
GFP and treated with EGF.  
CV-1 cells were transfected with NGFI-B-GFP, and treated with EGF (5 ng/ml) 10 min prior to nuclear FRAP. The 
slope from 0-22 s. was calculated. The data from 1 to 2 independent experiments were plotted as mean (A), or 
displayed as mean with SE (B) (n=4 or 9). *P < 0.05 compared with NGFI-B-GFP (unpaired t-test). 
 
 
The pre-bleach ratio of nuclear to cytoplasmic fluorescence was approximately equal with or 
without EGF treatment (data not shown).The results demonstrated that cells treated with EGF for 
10 min prior to nuclear photobleaching had a significantly decreased (~75 %) nuclear import of 
NGFI-B-GFP. 
 
3.3 Effects of Dominant Active or Dominant Negative ERK2 on Nuclear 
Import of NGFI-B 
ERK2 phosphorylates Thr 142 in the amino terminal of NGFI-B (Slagsvold et al., 2002) and is 
shown to diminish the concentration of NGFI-B in the cytoplasm (Jacobs et al., 2004). However, 
the results in section 3.2.2 demonstrated that the mutation mimicking phosphorylation of Thr 142 
in NGFI-B reduced the nuclear import of NGFI-B. It was therefore interesting to investigate 
whether a dominant active or negative ERK2 would increase or decrease nuclear import of 
NGFI-B-GFP. 
 
* 
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NGFI-B was co-transfected with dominant active or negative ERK2 in CV-1 cells (section 2.1.2), 
and nuclear FRAP was performed (section 2.1.5). Slopes from 0 s–22 s were calculated to 
quantify nuclear import. The results are presented in Figure 3.8. 
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Figure 3.8: Nuclear recovery of fluorescence after photobleaching in cells co-transfected with NGFI-B-GFP, 
and dominant active or negative ERK2. 
Nuclear FRAP was performed in CV-1 cells that were co-transfected with NGFI-B-GFP and dominant active ERK2 
(MEKERK2) or dominant negative ERK2 (KRERK2). The slopes from 0-22 s were calculated. Data from 2 
independent experiments were plotted as mean or displayed as mean with standard error (SE) (n=4 -10). 
 
 
The pre-bleach ratios of nuclear to cytoplasmic fluorescence were approximately equal between 
NGFI-B-GFP and NGFI-B-GFP co-transfected with dominant negative or active ERK2 (data not 
shown). The nuclear import of NGFI-B-GFP after photobleaching was reduced in cells over-
expressing dominant active ERK2 (~45 % reduction) or dominant negative ERK2 (~35 % 
reduction).  
 
3.4 Cerebellar Granule Neurons 
3.4.1 Glutamate-Induced Cell Death of CGN 
NGFI-B is highly expressed in neurons and is shown to translocate to mitochondria in glutamate-
exposed CGN. This translocation is inhibited by EGF, which is shown to activate ERK2 of the 
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MEK/ERK cascade in CGN (Jacobs et al., 2004). Retention of NGFI-B in the nucleus could 
protect cells from glutamate damage. However, ERK activation is also a consequence of 
glutamate exposure, in which the ERK activation contributes to cell death (Zhou et al., 2007).  
The effect of EGF stimulation of cells before glutamate exposure was assayed. The effect of 
MEK inhibitor U0126 on glutamate-induced death of CGN when added before or after glutamate 
exposure was also investigated, and dying cells were stained by trypan blue (section 2.4). In 
primary cultures, cell death may vary between the preparations, and experiments that induced 
~100 % cell death were disregarded because necrosis was likely to have contributed. The cell 
death counts are displayed in Figure 3.9. 
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Figure 3.9: Effect of MEK inhibitor U0126 and EGF on glutamate-induced cell death.  
CGN were incubated with MEK inhibitor U0126 1 h before (U0-1h), or 2 or 6 hrs after (U0+2h/6h) glutamate 
exposure to assay the effects on cell death. CGN were also pre-incubated with EGF (5 ng/ml) for 15 min prior to 
glutamate exposure, or just exposed to glutamate (glu). The results were displayed as mean with SE of cell death 
counts in percent of total cells (n=5-14). Data were from 5 independent experiments. *P < 0.05 compared to 
respective controls that were not exposed to glutamate (one way ANOVA with the Holm-Sidak method). #P < 0.05 
compared to glutamate exposure alone (Kruskal-Wallis one way ANOVA on ranks with Dunn’s method (equal 
variance failed). 
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All treatments with glutamate resulted in significantly higher cell death than the control 
exposures. The glutamate-induced cell death was significantly reduced by pre-incubation with 
EGF. Cell death induced by glutamate was not prevented by post-incubation with MEK inhibitor 
U0126. However, pre-incubation with U0126 slightly reduced the death of glutamate-exposed 
cells compared to cells exposed to buffer, in four out of five independent experiments. The 
buffer-exposed cells showed a reduced death by pre-incubation with U0126 in two out of five 
experiments if compared to cells only exposed to buffer. 
 
3.4.2 Subcellular Localization of NGFI-B and Apoptosis Inducing Factor in CGN 
The subcellular localization of NGFI-B in CGN was investigated in order to establish whether 
this in vitro model was suited for further studies of neuronal traffic of NGFI-B. AIF promotes 
apoptosis by translocation from mitochondria to the nucleus (Susin et al., 1999), and the 
subcellular localization AIF was therefore investigated as a marker of apoptotic mitochondrial 
activation. Rat CGN were exposed to physiological buffer or glutamate and double-
immunostained to visualize NGFI-B and AIF, while cell nuclei were stained with DAPI. The 
CGN were examined in a CLSM, and micrographs were displayed in Figure 3.10 and Figure 
3.11. 
Results  
 
 
52 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10: Micrographs of CGN that were exposed to glutamate or 
physiological buffer. Cells were DAPI- and immunostained. 
CGN were exposed to physiological buffer (A) or glutamate (B), fixed, and 
NGFI-B and AIF were immunostained to determine their subcellular 
localizations. Cell nuclei were stained by DAPI. The top left image depicts 
cells using differential interference contrast (DIC). The image in the middle of 
the top row shows DAPI-stained cells, while the top right image is an overlay 
of DIC and DAPI staining. The left image on the bottom row is an overlay of 
NGFI-B stained with CY-3 and DAPI, and in the lower middle image is FITZ- 
stained AIF overlaid with DAPI. The image to the bottom right is an overlay of 
immunostained NGFI-B and AIF. 
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Figure 3.11: Micrographs or CGN that were exposed to glutamate. Cells 
were DAPI- and immunostained. 
CGN were exposed to glutamate, fixed, and NGFI-B and AIF were 
immunostained to determine their subcellular localizations. Cell nuclei were 
stained by DAPI. The top left image of A and B shows cells using DIC. The 
image in the middle of the top row shows DAPI-stained cells, while the top 
right image is an overlay of DIC and DAPI staining. The left image on the 
bottom row is an overlay of NGFI-B stained with CY-3, and DAPI, and in the 
lower middle image is FITZ stained AIF overlaid with DAPI. The image to the 
bottom right is an overlay of immunostained NGFI-B and AIF. 
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In the majority of glutamate-exposed CGN, NGFI-B was distributed in the nucleus and in the 
cytoplasm, while AIF mainly was localized in the cytoplasm (B). This distribution was similar to 
that of CGN exposed to physiological buffer (A). The CLSM imaging revealed a small minority 
of glutamate-exposed CGN that showed a strongly reduced staining of AIF (C). Such cells had 
NGFI-B localized to both the cytoplasm and the nucleus. In a small fraction of the glutamate-
exposed cells, NGFI-B was not situated in the nucleus, only in the cytoplasm, and AIF displayed 
a similar distribution as NGFI-B in such cells (indicated by an arrow in D). 
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4 Discussion 
The orphan nuclear receptor NGFI-B (section 1.1) promotes the expression of survival molecules 
when acting as a transcription factor in the nucleus (Moll et al., 2006). However, in response to 
apoptotic stimuli, NGFI-B may translocate to mitochondria and trigger apoptosis (section 1.4.3) 
(Lin et al., 2004). This unique property of NGFI-B makes it a possible target for cancer 
therapeutics that promote apoptosis, and for pharmaceuticals that prevent neuronal apoptosis in 
neurodegenerative disorders. Many questions regarding the translocation of NGFI-B remain to be 
solved. This thesis will investigate several aspects regarding the regulation of NGFI-B migration. 
 
4.1 Establishment of a Luminometric ATP-assay with Over-Expressed 
Luciferase in Cell Lysates for Validation of ATP-Depletions 
4.1.1 Luminometric ATP-assay in CV-1 Cells 
An ATP-measuring assay was developed to verify that cells used in FRAP experiments (section 
4.3) were ATP-depleted. ATP is often determined by using a luciferin/luciferase reaction system 
(section 1.5.3) (Yang et al., 2002) where the production of bioluminescence is measured in a 
luminometer. The luciferase enzyme was produced by the transfection of rsv-luc plasmids into 
cells that later would over-express the enzyme. The luciferase enzyme was extracted by 
harvesting of the rsv-luc transfected cells, and could then be used to determine if ATP levels in 
cell lysates from ATP-depleted cells were decreased (section 4.2). 
 
The amount of luciferase-containing cell lysate that would be used to measure ATP was kept at a 
minimum to reduce background ATP and the presence of substances that could affect the 
luciferin/luciferase system. The results (Table 3.1) demonstrated that 10µl of cell lysate was the 
smallest measured amount that resulted in adequate ATP measurements. 
 
To establish the linear range in the luminometer, a dilution series of ATP was measured in every 
experiment. Measurements of the 2.4 x10-3 mg/ml ATP dilution were in the linear range (Figure 
3.1), and a 10-fold increase of the amount of added ATP yielded a 10-fold increase of signal. 
Consequently, subsequent measurements were going be in this range, and the 2.4 x10-3 mg/ml 
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ATP dilution would therefore be used as an internal standard. Measurements of the dilutions in 
separate experiments displayed great variations in RLU signals, strongly indicating that the 
concentration of luciferase varied in the cell lysates. Such variations could be a result of different 
transfection efficiencies or cell densities, and the comparison of absolute values between 
experiments was impractical in most experiments. It also became evident that measured values 
from one sample would slightly differ if measured several times. However, values were not 
obtained from multiple measurements of one sample because it was prioritized to measure all 
samples as quickly as possible to avoid decay of the luciferase enzyme or ATP. An exception was 
made with the negative control values that were the first and last measured sample from each 
round of cell harvest.  
 
To determine if substances present in the cell lysate could inhibit or augment the 
luciferin/luciferase reaction, the internal ATP standard was added to the cell lysate of non-
transfected cells and measured. The results (Table 3.2) did not display the increase of signal that 
would correlate to the increase of added ATP. The 10-fold increase of signal from the 10-fold 
increase of added ATP in the preceding measurement (Figure 3.1 B) displayed such a correlation. 
Accordingly, there were substances in the cell lysate that quenched the signal, such as ATPases 
or other energy consuming enzymes that depleted ATP, and/or substances that otherwise 
interfered with the luciferin/luciferase reaction. To address these issues, cells were either 
harvested in TCA that would precipitate proteins, or in boiling water that would denature proteins 
that quenched the RLU signal. In addition, cell lysate from cells harvested according to the 
original protocol was boiled.  
 
Cells were harvested in solutions containing TCA as a modification of an existing ATP 
measurement procedure used by Berg-Johansen et al. (1993). When non-transfected cells were 
harvested in TCA, the RLU signal was reduced to zero (Table 3.3). This indicated that not only 
ATP-depleting enzymes, but also the luciferase enzyme, was precipitated to such an extent that 
there was not enough enzyme left to catalyze the luciferin oxidation reaction. Consequently, cells 
were not harvested in solutions containing TCA in subsequent experiments. A method developed 
by Yang et al. (2002), in which cells were harvested in boiling MQ-H2O, was reported to inhibit 
ATPases and not to interfere with the bioluminescence. This method, in addition to boiling of 
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conventionally harvested cell lysates, was assayed. The boiling methods still resulted in 
quenching of the RLU values (Table 3.4 and Table 3.5). However, the loss of signal was reduced 
by approximately 70 % when the cell lysate was boiled after harvest, if compared to cell lysate 
that was not boiled (Figure 3.2). This indicates that the substances that quenched the RLU signal 
were eliminated to some extent. Quenching was similar at all ATP concentrations measured, and 
the method could therefore be used to determine percent ATP depletion in subsequent 
experiments (section 4.2 and 4.3).  
  
4.2 ATP-Depletion of CV-1 Cells 
ATP-depleted and non-depleted CV-1 cells were later going to be used in FRAP experiments to 
determine if nuclear import of NGFI-B was energy-dependent (section 3.2.1). The CV-1 cells 
were ATP-depleted in a glucose-free medium that was supplemented with sodium azide 
according to a procedure by Goda et al. (2002). Cells depleted for various time periods were 
harvested and measured to determine the required duration of the ATP-depletion procedure.  
 
The results demonstrated that ATP-depletion for six hours strongly reduced RLU signals 
compared to signals from non-depleted cells, while shorter ATP-depletion resulted in a small 
reduction of signal. The ATP-depletion of CV-1 cells by sodium azide was slow compared to the 
ATP-depletion for 30 minutes in human epidermoid carcinoma cells and mouse fibroblasts by 
Goda et al. (2002). However, the cells that were depleted over night were no longer attached to 
the plastic surface of the culture dish. This strongly indicates that the cells were injured or dead. 
The cells that were depleted for six hours had a normal morphology and were attached to the 
culture dish, and this duration of ATP depletion was therefore used in FRAP experiments 
(section 4.3). 
 
4.3 FRAP Experiments to Determine if Nuclear Import of NGFI-B is Energy-
Dependent 
The nuclear receptor NGFI-B has a molecular weight of 61 kDa (Fahrner et al., 1990), and is 
therefore too large to passively diffuse through nuclear pores. However, NGFI-B contains two 
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NLSs (Hsu et al., 2004) and is consequently a candidate for energy-consuming nuclear import 
pathways (section 1.2). To determine if nuclear import of NGFI-B is energy-dependent, NGFI-B-
GFP was over-expressed in CV-1 cells, and FRAP experiments were performed before and after 
ATP-depletion of cells. The molecular weight of GFP is 27 kDa and it would therefore be small 
enough to passively diffuse through NPC. Furthermore, a similar concentration of GFP in both 
the nucleus and the cytoplasm (Figure 3.3) was suggested by Xiao et al. (2000) to indicate the 
absence of a NLS in GFP. Consequently, GFP was used as a control protein.  
 
Cells with a slightly more fluorescent nucleus than cytoplasm after transfection with NGFI-B-
GFP were visually selected for photobleaching (10-20 % of cells, data not shown). This made it 
possible to identify the nuclei, and at the same time have enough visible fluorescent molecules in 
the cytoplasm to obtain a recovery of fluorescence in the bleached nuclei (Figure 3.3). Such a 
distribution also resembled the subcellular localization of the over-expressed control protein, 
GFP.  
 
The results demonstrated that nuclear import of NGFI-B was reduced by ATP-depletion (Figure 
3.4). The depletion of ATP would also have diminished other nucleoside triphosphates generated 
by phosphate transfer from ATP to nucleoside diphosphates catalyzed by diphosphate kinases 
(Mourad and Parks, 1965). Consequently, the Ran GTPases that provided energy for nuclear 
import pathways would be depleted as well. It was demonstrated by Schwoebel et al. (2002) that 
ATP-depletion inhibited Ran-dependent nuclear import, and that such inhibition resulted from a 
shortage of RanGTP rather than the inhibition of some ATP-dependent process.  The reduction of 
nuclear import of NGFI-B in ATP-depleted CV-1 cells therefore indicates that nuclear import of 
NGFI-B is energy-dependent. Alternatively, the nuclear import of NGFI-B could have been 
reduced by cell injuries as a consequence of the ATP-depletion. ATP-depletion is known to cause 
a series of cellular injuries that possibly could have affected the nuclear import of NGFI-B, 
including elevated intracellular calcium, loss of membrane-cytoskeleton linkage, and alteration of 
the function and/or aggregation of membrane proteins (Chen et al., 1997; Chen et al., 1994; Chen 
and Wagner, 2001; Haggie et al., 2002; Wheeler et al., 2000). However, visual differences in the 
microscope between cells that were ATP-depleted and the non-depleted cells were not detected 
(data not shown). This indicated that the cells were not severely damaged.  
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To optimize the FRAP assay, it would be recommended in future experiments to use another 
control protein than GFP. This protein should be the same size as NGFI-B, but without any 
sequences that could affect nuclear import or export, and it should be fused to GFP. NGFI-B has 
the molecular weight of 60 kDa, and the adding of GFP to NGFI-B made the molecule 87 kDa. 
The increase in size could possibly have affected the nuclear import of NGFI-B. In future 
experiments, this issue could be avoided by removing a 27 kDa part from NGFI-B. However, it 
would be crucial that the removed section does not contain features that are essential for the 
import pathways recognition of cargo, or that it affects other features of the nuclear import. 
 
4.4 Nuclear FRAP of CV-1 cells Over-Expressing Threonine to Alanine or 
Glutamate Mutated NGFI-B 
The subcellular localization of NGFI-B is reported to be regulated by phosphorylations of 
multiple serine and threonine sites (Han et al., 2006; Kang et al., 2000; Li et al., 2000; Slagsvold 
et al., 2002). Heavily phosphorylated NGFI-B is predominant in the cytoplasm while less 
phosphorylated NGFI-B localizes to the nucleus (Fahrner et al., 1990). Jacobs et al. (2004) have 
previously demonstrated that the growth factor EGF activated the MAP kinase ERK2, and 
inhibited apoptosis-induced translocation of NGFI-B from the nucleus to the mitochondria. As 
EGF stimulation is shown to lead to phosphorylation of NGFI-B in PC12 cells (Hazel et al., 
1991), and since the threonine 142 of NGFI-B is phosphorylated in vitro ERK2 (Slagsvold et al., 
2002), the Thr 142 phosphorylation could be involved in the accumulation of NGFI-B in the 
nucleus. Nuclear import of NGFI-B was demonstrated to be energy-dependent in this thesis 
(section 4.3) and the presence of NLSs and NESs in NGFI-B makes it a potential cargo for 
classical nuclear import/export pathways. It was therefore interesting to examine whether 
phosphorylation of Thr 142 increased the rate of nuclear import of NGFI-B, and if elimination of 
phosphorylation of this site decreased this import. 
 
CV-1 cells were transfected with NGFI-B-GFP, NGFI-B-GFP with a threonine 142 to alanine 
mutation (NGFI-B-T142A-GFP) that blocked phosphorylation of this residue, and NGFI-B-GFP 
with a threonine to glutamate mutation (NGFI-B-T142E-GFP) that functionally mimicked the 
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charge conferred by the phosphate. Nuclear recovery of the fluorescent proteins after 
photobleaching of the nuclei was assayed to investigate differences in nuclear import. 
 
Surprisingly, the nuclear recovery of NGFI-B-GFP was slightly increased by blocking 
phosphorylation of Thr 142 (Figure 3.5). However, the similar recovery of NGFI-B-GFP and 
NGFI-B-T142A-GFP suggests that NGFI-B-GFP was basally non-phosphorylated at this residue. 
NGFI-B with a 142 Thr to Glu mutation that mimicked phosphorylation displayed a reduced 
recovery in the nucleus after photobleaching (Figure 3.5). These results indicate that the 
glutamate mutation affected NGFI-B as cargo for nuclear import pathways in such a manner that 
nuclear import was decreased.  
 
Differences between the pre-bleach subcellular distribution of NGFI-B-GFP, NGFI-B-T142A-
GFP, or NGFI-B-T142E-GFP were not visually detected. In a majority of CV-1 cells (80-90 %, 
data not shown), the concentration of fluorescent protein was higher in the nucleus than in the 
cytoplasm. However, a further increase of nuclear fluorescence would have been difficult to 
visually detect. If one of the fluorescent proteins demonstrated an increased import and 
localization to the nucleus, it would possibly have a decreased concentration in the cytoplasm. 
During bleaching of the nucleus, the remaining cytoplasmic proteins would have a rapid import 
in to the nucleus, where they would have been bleached. The amount of cytoplasmic fluorescent 
protein would thereby have been further reduced. Nuclear FRAP performed on such a cell would 
result in a slow recovery of nuclear fluorescence in despite of the high nuclear import rate. To 
address these issues, the ratio of nuclear to cytoplasmic fluorescence before bleaching was 
calculated (Figure 3.6). The exact values of nuclear fluorescence could not be used because the 
gain was changed within experiments, and thereby, the pixel intensity was also changed. A 
constant gain could not be sustained, as this reduced the visibility of a number of cells that was 
required to outline the nucleus for bleaching, and saturated others. The results demonstrated that 
NGFI-B-GFP had the highest fraction of total fluorescence in the nucleus, while that of BT142A-
GFP was slightly lower. NGFI-B-T142E-GFP had the lowest nuclear to cytoplasmic ratio. These 
results confirmed a reduced nuclear import of NGFI-B-GFP with a Thr 142 Glu mutation that 
mimicked phosphorylation, and that this was not an effect of reduced cytoplasmic fluorescence. 
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Experiments by Slagsvold et al.(2002) demonstrated that EGF activated ERK2, and that ERK2 
phosphorylated Thr 142 of NGFI-B. Furthermore, NGFI-B-GFP treated with EGF was 
documented to localize to the nuclei of CV-1 cells in a paper by Jacobs et al. 2004. However, in 
the experiments presented in the current thesis, translocation of NGFI-B-GFP into the nucleus 
may not be due to phosphorylation of Thr 142 by ERK2, as the nuclear import of NGFI-B was 
reduced by mimicking of this phosphorylation. Surprisingly, results also demonstrated that EGF-
treatment of CV-1 cells resulted in a significantly reduced nuclear import of NGFI-B (Figure 
3.7). It is tempting to speculate that EGF activated ERK2, which in turn phosphorylated Thr 142 
of NGFI-B-GFP and thereby reduced nuclear import. In addition to phosphorylation of NGFI-B,  
ERK2 could have phosphorylated proteins involved in the regulation of nuclear import (Poon and 
Jans, 2005). Interestingly, several NPC proteins (nucleoporins, Nups) are themselves modified 
via phosphorylation by kinases that are involved in phosphorylation of NGFI-B (Eblen et al., 
2003; Frosst et al., 2002).  
 
EGF and phosphorylation of NGFI-B-GFP Thr 142 does not seem to have the same effects in 
experiments performed in this thesis and by Jacobs et al. (2004). The experiments were 
performed in the same laboratory and within the same CV-1 cell line. However, the serum batch 
used in the culture media was changed, in addition to thawing of new cells. These factors could 
have contributed to the observed alterations by a different composition of mitogens or other 
substances in serum, or an alteration within the cells themselves. NGFI-B-GFP in the present 
thesis had a higher concentration in the nucleus of the majority of CV-1 cells (Figure 3.3), while 
it was evenly distributed in the results presented by Jacobs et al (2004). This suggests that a 
change in the cell line has taken place. The subcellular distribution of NGFI-B is known to differ 
between cell lines (Fahrner et al., 1990). Interestingly, the effect of EGF is also known do 
diverge; it is known to be a potent growth factor (Jorissen et al., 2003), while in some tumor cell 
lines, EGF stimulation results in apoptosis (Chen et al., 2004; Kottke et al., 1999; Zhao et al., 
2006). Accordingly, there are a number of factors that could have contributed to the different 
results demonstrated by Jacobs et.al. (2004) and the present thesis. Additional experiments in 
order to reveal the cause of the alteration may further enlighten the mechanisms of the 
MEK/ERK pathway and translocation of NGFI-B. 
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In summary, by mimicking a phosphorylation of Thr 142 of NGFI-B-GFP, the nuclear import of 
the nuclear receptor was reduced compared to non-mutated NGFI-B. By blocking this 
phosphorylation, the nuclear import of NGFI-B-GFP was slightly increased. One of the most 
common mechanisms for down- regulating the efficiency of nuclear import is masking of NLSs 
within cargo proteins to prevent recognition by importins. The NLS can be masked by altered 
charge or conformational change due to phosphorylations (Poon and Jans, 2005). It is tempting to 
speculate that phosphorylation of Thr 142 in the N-terminal of NGFI-B masked one of the NLSs 
located in the C-terminus.  
 
4.5 Nuclear FRAP in CV-1 cells over-expressing NGFI-B and Dominant 
Active or Negative ERK2 
The MAP kinase ERK2 was demonstrated to phosphorylate Thr 142 in the amino terminal of the 
nuclear receptor NGFI-B (Slagsvold et al., 2002). In studies by Jacobs et al. (2004) and Jacobs 
and Paulsen (2005), NGFI-B-GFP expressed in the presence of dominant active ERK2 localized 
to the nucleus of CV-1 cells. These results suggested that phosphorylation of Thr 142 by ERK2 
increased nuclear targeting of NGFI-B. However, results in section 4.4 demonstrated that by 
mimicking phosphorylation of Thr 142 in NGFI-B, nuclear import of NGFI-B was reduced. It 
was therefore interesting to investigate whether dominant active or dominant negative ERK2 
would increase or decrease nuclear import of NGFI-B-GFP. NGFI-B-GFP was co-transfected 
with dominant active or dominant negative ERK2 in CV-1 cells, and nuclear FRAP was 
performed. 
 
The nuclear import of NGFI-B-GFP after photobleaching was reduced by over-expressed 
dominant active ERK2 (Figure 3.8). This reduction could be a result of the phosphorylation of 
NGFI-B by ERK2 that was demonstrated by Slagsvold et al. (2002). The reduction of nuclear 
import of NGFI-B by Thr 142 phosphorylation was also suggested by results in section 4.5, in 
which Thr was mutated to Glu to mimic constitutive phosphorylation of this residue. 
Furthermore, it was demonstrated that EGF, which activates ERK2, reduced the nuclear import of 
NGFI-B-GFP.  
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Visual inspections using the CLSM did not reveal an increased concentration of nuclear NGFI-B-
GFP when co-expressed with active ERK2 (data not shown), as previously described by Jacobs 
and Paulsen (2005). However, in the CV-1 cells used in this thesis, the concentration of NGFI-B-
GFP in the nucleus was higher than in the cytoplasm (section 4.4). Consequently, an increased 
nuclear localization of NGFI-B-GFP would have been difficult to visually detect. However, EGF 
which activates ERK2 was shown to reduce the nuclear import of NGFI-B-GFP in this thesis, 
while Jacobs et al. demonstrated an increase. This suggests that changes have occurred in the 
CV-1 cell line or in the serum used in the culture medium (section 4.4). If so, an increase of 
nuclear concentration of NGFI-B-GFP expressed with dominant active ERK2 in the CV-1 cells 
used in this thesis might not have taken place. The fact that ERK2 signaling resulted in such 
different responses in the CV-1 cells could be explained by involvement of ERK2 in regulation 
of as divergent processes as cell death and proliferation. Although ERK generally has been 
considered to be involved in a survival signaling pathway, experiments demonstrate that ERK 
may mediate apoptosis in CGN (Subramaniam et al., 2004), numerous cell lines, and in vivo  
(Zhuang and Schnellmann, 2006). 
 
Nuclear FRAP performed on cells co-expressing NGFI-B-GFP and dominant negative ERK2 
demonstrated a reduced nuclear import of NGFI-B-GFP (Figure 3.8). It was previously 
demonstrated in this thesis that by blocking phosphorylation of Thr 142 by mutation, the nuclear 
import of NGFI-B was not affected, and that NGFI-B possibly exhibit a basal non-
phosphorylation of Thr 142. These results suggest that nuclear import of NGFI-B was not 
affected by a lack of ERK2 phosphorylation of Thr 142. The reduction of recovery is then likely 
to have another origin. The over-expression of dominant negative ERK2 could possibly influence 
a number of cellular processes that affect nuclear import. Preliminary studies (data not shown) 
also suggest that the reduction of nuclear import of NGFI-B-GFP by dominant negative ERK is 
non-specific. 
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4.6 Effects of the MEK/ERK pathway on Glutamate-Induced Cell Death in 
Cerebellar Granule Neurons 
Activation of the MEK/ERK pathway by glutamate via the NMDAR is involved in mammalian 
memory and learning (Bading and Greenberg, 1991; Kurino et al., 1995; Mao et al., 2004; 
Perkinton et al., 2002; Platenik et al., 2000). However, activation of ERK during 
neuropathological over-stimulation of NMDARs may contribute to neuronal death in the adult 
brain (Jiang et al., 2000). Upon activation, ERK dimerizes and translocates to the nucleus 
(Khokhlatchev et al., 1998). Such an activation of ERK is induced by EGF, and the effect of EGF 
stimulation before glutamate exposure was therefore investigated in cultured rat cerebellar 
granule neurons (CGN). The CGN express glutamate responsive NMDA receptors and are a 
much used in vitro model for studying neuronal apoptosis (Xia et al., 1995a). The glutamate 
exposure of the CGN represented a relatively mild insult of glutamate toxicity (100 µM) that 
would initiate apoptosis rather than necrosis. Dying cells were stained with trypan blue and 
counted.  
 
The results (Figure 3.9) demonstrated a significant reduction of glutamate-induced cell death in 
CGN that were treated with EGF. The reduction of cell death indicated that EGF had a 
neuroprotective effect in the CGN, an effect previously presented by Abe and Saito (1992) and 
Gunn-Moore and Tavare (1998), and that possibly was mediated by the activation of ERK. The 
relevance of MEK/ERK pathways in neuronal cell survival was documented in PC12 
pheochromocytoma cells, in which down-regulation of ERK mediated by NGF withdrawal led to 
apoptosis, whereas the activation of the ERK signaling pathway by NGF inhibited apoptosis (Xia 
et al., 1995b). Such a protective effect of ERK could have taken place when cells were treated 
with EGF, as demonstrated by Jacobs et al., or the protection by EGF could have been mediated 
through other pathways.  
 
In addition to having a protective effect, the activation of ERK is a consequence of glutamate 
exposure, in which the phosphorylation of ERK was demonstrated to contribute to neuronal death 
(Subramaniam et al., 2004; Zhou et al., 2007). In cortical neurons, the cells committed to 
apoptosis in response to glutamate if the activation of ERK was persistent (Stanciu et al., 2000). 
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It was therefore interesting to investigate whether MEK inhibitor U0126, which inhibits the 
MEK/ERK cascade, would inhibit or augment glutamate-induced cell death in CGN if distributed 
at different time-points. The results (Figure 3.9) demonstrated that MEK-inhibition subsequent to 
glutamate exposure did not affect glutamate-induced cell death. Consequently, a continuous 
activation, and thereby sustained nuclear accumulation of ERK, was not involved in the 
glutamate-mediated cell death of the CGN. However, MEK inhibitor administered prior to 
glutamate exposure resulted in a small reduction of glutamate-induced cell death (Figure 3.9). 
This tendency suggests that the MEK/ERK signaling pathway was not involved in survival of the 
CGN, as this would have resulted in an increased cell death when MEK was inhibited. The small 
reduction of cell death by early MEK inhibition suggests that ERK somehow was involved in the 
cell death induced by glutamate. A greater reduction of glutamate-mediated cell death resulting 
from MEK inhibition in advance of glutamate exposure was previously demonstrated in CGN 
(Debernard K.B., UIO, personal communication). These results indicate that the early activation, 
and thereby early nuclear accumulation of activated ERK, is involved in the mediation of 
glutamate-induced cell death in CGN.  
 
In summary, the subcellular distribution of ERK may be involved in the early promotion of 
glutamate-induced cell death, and the ERK induced by EGF and glutamate may have different 
functions in CGN. Multiple functions of ERK could result from two distinct kinds of ERKs that 
were either activated by EGF via EGF receptors, or by glutamate via the NMDAR. Furthermore, 
glutamate is previously shown to have different effects on ERK depending on which NMDAR 
that was activated. Ivanov et al. (2006) demonstrated that activation of the NR2B subunit in 
synaptic NMDAR was responsible for ERK phosphorylation and activation, while stimulation of 
the extrasynaptic NR2B contributed to ERK dephosphorylation and inactivation. 
 
To further pursue the involvement of ERK in neuronal apoptosis, it would be interesting to 
examine whether glutamate- and EGF-activated ERK may signal differently to downstream 
mediators, such as NGFI-B. The CGN appears to be a suitable model for such investigations, due 
to the glutamate-induced cell death, EGF receptors, activation of ERK by EGF, and possibly by 
glutamate. To assay whether NGFI-B is equally phosphorylated by glutamate and EGF by using 
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a proteomic approach would be interesting, as well as to over-express the NGFI-B mutants 
presented in section 4.4 followed by FRAP studies. In addition, studies of the wt protein also 
have to be conducted, and the effects of glutamate and EGF on the subcellular localization of 
NGFI-B in the CGN should be investigated. 
 
4.7 The Subcellular Distribution of NGFI-B and AIF in CGN 
The subcellular localization of NGFI-B in CGN was investigated in order to establish whether 
this in vitro model was suited for further studies of neuronal traffic of NGFI-B. Mitochondrial 
association of NGFI-B is demonstrated to result in apoptotic activation of mitochondria, which 
facilitates the release of apoptotic factors such as AIF (Lin et al., 2004). AIF translocates from 
the mitochondria to the nucleus, and the subcellular localization AIF was therefore investigated 
as a marker of apoptotic mitochondrial activation. By double immunostaining of CGN exposed to 
glutamate or physiological buffer, translocation of NGFI-B to the mitochondria and AIF to the 
nucleus of the same cell was investigated. 
 
In the majority of CGN that were exposed to glutamate, NGFI-B localized to both the cytoplasm 
and the nucleus. Such a distribution was similar to that of CGN exposed to physiological buffer, 
and indicated that there were few apoptotic cells on the glutamate-exposed cover glasses. The 
immunostained cells were from the same experiments as the cells that were assayed for cell death 
in section 4.6. Glutamate induced cell death in a majority of such cells, and would also have done 
so in the immunostained cells. However, the CGN for cell counts were incubated over night 
subsequent to glutamate exposure, whereas cells for immunostaining were incubated for two 
hours. Previous studies had shown translocation of AIF in CGN at this time-point (Slagsvold et 
al., 2003). However, the translocation of NGFI-B was possibly not initiated after two hours in the 
CGN investigated in this thesis, and additional time-points could reveal if translocation would 
take place in more cells if they were fixed at a later time. To enable CLSM imaging, the 
immunostained CGN were grown on glass, whereas CGN for cell counts were grown on plastic. 
CGN are known to grow poorly on glass, and the cell density on the cover glasses was low 
compared to cell densities in plastic culture dishes (data not shown). Possibly, the apoptotic cells 
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displayed an even poorer adherence to glass and fell off or were washed away during the 
immunostaining procedure.  
 
In a majority of the glutamate-exposed cells, AIF mainly localized to the cytoplasm. The absence 
of AIF translocation to the nucleus could be an additional indication of few apoptotic cells. In 
some glutamate-exposed cells, the staining of AIF was strongly reduced and a translocation of 
AIF would have been difficult to detect. 
 
NGFI-B localized to the cytoplasm, and not the nucleus, in a minority of the glutamate-exposed 
cells. Such cells appeared to be condensed, and were possibly apoptotic. However, AIF was also 
localized to the cytoplasm in the condensed cells, and the sole translocation of NGFI-B-GFP 
possibly indicates that the two processes occur at different times. It was reported by Munoz-
Pinedo et al. (2006) that the mitochondrial release of AIF proceeds more slowly than the release 
of other apoptogenic proteins such as cytochrome c (hour-range for AIF as compared to minute-
range for other apoptogenic proteins), although the release starts simultaneously. Alternatively, 
the glutamate-induced apoptosis in the CGN was a caspase dependent cell death without caspase-
independent pathways involving AIF (discussed with Dawson,T., Johns Hopkins University, 
USA). In a caspase dependent apoptosis, cytochrome c could be used as a marker of 
mitochondrial activation. 
 
4.8 Conclusions
o A luminometric ATP-assay with over-expressed luciferase from CV-1 cells was 
established and applied in the validation of ATP depletions. 
o The nuclear import of NGFI-B was energy-dependent. 
o A Thr to Glu mutation reduced the nuclear import of NGFI-B. 
o The nuclear import of NGFI-B was reduced by EGF. 
o Co-expression with dominant active ERK2 reduced the nuclear import of NGFI-B. 
o Glutamate-induced cell death of CGN was slightly reduced by inhibition of the 
MEK/ERK pathway. 
o CGN may be used as a model for determination of neuronal NGFI-B traffic. 
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Appendix 
Appendix 1: Chemicals and biological products 
Product Manufacturer 
AIF (D-20) Mouse anti-goat polyclonal IgG (Lot C2906) Santa Cruz Biotechnology, Inc.  
California,USA. 
Ara-C Sigma-Aldrich Co. 
St. Louis, USA. 
ATP Sigma-Aldrich Co. 
BES Sigma-Aldrich Co. 
BME Invitrogen Co.  
California, USA. 
BSA Invitrogen Co.  
CaCl2 Merck & Co., Inc. 
New Jersey, USA. 
Cy™ 3-conjugated mouse anti-rabbit IgG Jackson ImmunoResearch Laboratories, Inc.  
Pennsylvania, USA.  
DAPI Sigma-Aldrich Co. 
D-Luciferin Duchefa 
Haarlem, The Netherlands. 
D-MEM Invitrogen Co.  
DMSO Sigma-Aldrich Co. 
DnaseI Sigma-Aldrich Co. 
DTT Sigma-Aldrich Co. 
EGF PeproTech Inc. 
New Jersey, USA. 
FBS Invitrogen Co. 
FITC Mouse anti-goat IgG (No AP1867) Millipore Co. 
Massachusetts, USA. 
FluoroSaveTM Reagent EMD Chamicals  
California, USA. 
Gentamicin sulfate Sigma-Aldrich Co. 
Glucose Merck & Co., Inc. 
Glycine Sigma-Aldrich Co. 
HEPES Sigma-Aldrich Co. 
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KCl Genzyme Pharmaceuticals 
Massachusetts, USA. 
KH2PO4 Merck & Co., Inc. 
L-Glutamate Sigma-Aldrich Co. 
L-Glutamine Sigma-Aldrich Co. 
MEK inhibitor U0126 Promega Co. 
Wisconsin, USA. 
MES Sigma-Aldrich Co. 
Mg(CH3COO)2 Merck & Co., Inc. 
MgCl2 x 7H2O Merck & Co., Inc. 
MgSO4 Merck & Co., Inc. 
Na pyruvate Sigma-Aldrich Co. 
Na2HPO4 . H2 Merck & Co., Inc. 
NaCl Mallinckrodt Baker B.V. 
Deventer, The Netherlands. 
NaHCO3 Sigma-Aldrich Co. 
NaN3 Merck & Co., Inc. 
Normal mouse serum Jackson ImmunoResearch Laboratories, Inc. 
Nur-77 (M-210) Mouse anti-rabbit polyclonal IgG (Lot 
E1106) 
Santa Cruz Biotechnology, Inc.  
Penicillin-streptomycin (10 000U/ml / 10 000µl/ml)  Invitrogen Co.  
PFA Electron Microscopy Sciences 
Pennsylvania, USA. 
Phenol red Merck & Co., Inc. 
Poly-L-lysine Sigma-Aldrich Co. 
TCA Sigma-Aldrich Co. 
Tris MP Biomedicals 
Ohio, USA 
Triton X-100 Sigma-Aldrich Co. 
Trypan blue Sigma-Aldrich Co. 
Trypsin Sigma-Aldrich Co. 
Trypsin inhibitor Sigma-Aldrich Co. 
Trypsin-EDTA Invitrogen Co. 
 
